{"id":403647,"date":"2026-01-22T00:06:00","date_gmt":"2026-01-21T16:06:00","guid":{"rendered":"https:\/\/pingtungtimes.com.tw\/?p=403647"},"modified":"2026-01-22T00:06:00","modified_gmt":"2026-01-21T16:06:00","slug":"syngene-international-%e5%bb%b6%e9%95%b7%e8%88%87-bristol-myers-squibb-%e7%9a%84%e9%95%b7%e6%9c%9f%e7%a7%91%e7%a0%94%e5%90%88%e4%bd%9c%e8%87%b3-2035-%e5%b9%b4","status":"publish","type":"post","link":"https:\/\/pingtungtimes.com.tw\/?p=403647","title":{"rendered":"Syngene International \u5ef6\u9577\u8207 Bristol Myers Squibb \u7684\u9577\u671f\u79d1\u7814\u5408\u4f5c\u81f3 2035 \u5e74"},"content":{"rendered":"
\n\n\n\n
<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u5370\u5ea6\u73ed\u52a0\u7f85\u723e<\/span>2026\u5e741\u670821\u65e5<\/span> \/\u7f8e\u901a\u793e\/ — \u5168\u7403\u5408\u7d04\u7814\u7a76\u3001\u958b\u767c\u53ca\u88fd\u9020\u6a5f\u69cb (CRDMO) Syngene International \u4eca\u65e5\u5ba3\u4f48\uff0c\u5c07\u5176\u8207 Bristol Myers Squibb \u4e4b\u9593\u9577\u671f\u7684\u7b56\u7565\u6027\u5408\u4f5c\u95dc\u4fc2\u5ef6\u9577\u81f3 2035 \u5e74\u3002 \u64f4\u5c55\u5f8c\u7684\u5354\u8b70\u9032\u4e00\u6b65\u64f4\u5927\u4e86\u6574\u5408\u670d\u52d9\u7684\u7bc4\u7587\uff0c\u6db5\u84cb\u85e5\u7269\u958b\u767c\u5168\u751f\u547d\u9031\u671f\uff0c\u5f9e\u7814\u767c\u63a2\u7d22\u968e\u6bb5\uff08\u5305\u62ec\u5316\u5b78\u3001\u751f\u7269\u5b78\u3001\u85e5\u7269\u4ee3\u8b1d\u8207\u85e5\u7269\u52d5\u529b\u5b78\uff09\u3001\u8f49\u8b6f\u79d1\u5b78\u3001\u88fd\u85e5\u958b\u767c\u8207\u88fd\u9020\u3001\u81e8\u5e8a\u8a66\u9a57\uff0c\u4ee5\u81f3\u6578\u64da\u8207\u8cc7\u8a0a\u79d1\u6280\u670d\u52d9\uff0c\u4ee5\u5be6\u73fe\u7531\u79d1\u7814\u5230\u5546\u696d\u5316\u7684\u7121\u7e2b\u63a8\u9032\u3002 \u6b64\u6b21\u5408\u4f5c\u7684\u64f4\u5c55\u6a19\u8a8c\u7740\u96d9\u65b9\u9081\u5165\u4e0b\u4e00\u968e\u6bb5\u7684\u589e\u9577\uff0c\u4e26\u9032\u4e00\u6b65\u978f\u56fa Syngene \u4f5c\u70ba\u7b56\u7565\u6027\u5408\u4f5c\u5925\u4f34\u7684\u5730\u4f4d\uff0c\u6301\u7e8c\u63d0\u4f9b\u6574\u5408\u5f0f\u3001\u7aef\u5230\u7aef\u7684\u79d1\u7814\u8207\u88fd\u9020\u89e3\u6c7a\u65b9\u6848\u3002<\/p>\n

Syngene International Ltd. <\/b>\u8463\u4e8b\u7e3d\u7d93\u7406\u517c\u884c\u653f\u7e3d\u88c1\u00a0Peter Bains <\/b>\u8868\u793a\uff1a<\/b>\u00a0\u300c\u6211\u5011\u8207\u00a0Bristol Myers Squibb <\/i>\u7684\u5408\u4f5c\u95dc\u4fc2\u81f3\u4eca\u5df2\u903e\u00a025 <\/i>\u5e74\uff0c\u4e26\u4ee5\u5353\u8d8a\u79d1\u7814\u3001\u71df\u904b\u53ef\u9760\u6027\uff0c\u4ee5\u53ca\u5171\u540c\u63a8\u52d5\u5275\u65b0\u7642\u6cd5\u767c\u5c55\u7684\u627f\u8afe\u70ba\u57fa\u790e\u3002 <\/i>\u5c07\u5408\u4f5c\u5925\u4f34\u95dc\u4fc2\u5ef6\u9577\u81f3\u00a02035 <\/i>\u5e74\u7684\u5354\u8b70\uff0c\u8b93\u6211\u5011\u80fd\u4ee5\u9577\u9054\u5341\u5e74\u6642\u9593\u7684\u8996\u91ce\uff0c\u5171\u540c\u898f\u5283\u672a\u4f86\u5728\u65b0\u80fd\u529b\u53ca\u57fa\u790e\u8a2d\u65bd\u65b9\u9762\u7684\u5efa\u8a2d\u3002 <\/i>\u63a1\u53d6\u9577\u9060\u8996\u89d2\u662f\u6211\u5011\u5408\u4f5c\u95dc\u4fc2\u7684\u95dc\u9375\u7279\u9ede\uff0c\u70ba\u96d9\u65b9\u4f01\u696d\u5e36\u4f86\u7b56\u7565\u6027\u50f9<\/i>\u503c\u3002 <\/i>\u6211\u5011\u671f\u5f85\u652f\u63f4\u00a0BMS <\/i>\u4e0b\u4e00\u6ce2\u7684\u767c\u73fe\u3001\u958b\u767c\u53ca\u88fd\u9020\u8a08\u5283\uff0c\u9019\u4e9b\u9805\u76ee\u6709\u6f5b\u529b\u70ba\u5168\u7403\u60a3\u8005\u5e36\u4f86\u66f4\u4f73\u7684\u6cbb\u7642\u6210\u679c\u3002\u300d<\/i><\/p>\n

Bristol Myers Squibb <\/b>\u6cbb\u7642\u767c\u73fe\u79d1\u5b78\u9ad8\u7d1a\u526f\u7e3d\u88c1\u00a0Payal Sheth <\/b>\u8868\u793a\uff1a<\/b>\u00a0\u300c\u5728\u00a0Bristol Myers Squibb<\/i>\uff0c\u6211\u5011\u6240\u505a\u7684\u4e00\u5207\u90fd\u4ee5\u60a3\u8005\u70ba\u8d77\u9ede\u3002 <\/i>\u6211\u5011\u975e\u5e38\u91cd\u8996\u8207\u00a0Syngene <\/i>\u4e4b\u9593\u6b77\u4e45\u5f4c\u65b0\u7684\u5408\u4f5c\u5925\u4f34\u95dc\u4fc2\uff0c\u8a72\u5408\u4f5c\u5728\u63a8\u52d5\u6211\u5011\u7684\u79d1\u7814\u62b1\u8ca0\u65b9\u9762\u767c\u63ee\u4e86\u95dc\u9375\u4f5c\u7528\u3002 <\/i>\u6b64\u6b21\u5408\u4f5c\u7684\u64f4\u5c55\uff0c\u9ad4\u73fe\u4e86\u6211\u5011\u900f\u904e\u6709\u6548\u6574\u5408\u79d1\u7814\u3001\u958b\u767c\u53ca\u88fd\u9020\u80fd\u529b\uff0c\u63a8\u9032\u5275\u65b0\u79d1\u5b78\u7684\u627f\u8afe\uff0c\u4ee5\u52a0\u5feb\u5177\u7a81\u7834\u6027\u7684\u85e5\u7269\u4ea4\u4ed8\uff0c\u70ba\u5168\u7403\u6b63\u7b49\u5f85\u65b0\u6cbb\u7642\u65b9\u6848\u7684\u60a3\u8005\u5e36\u4f86\u5e0c\u671b\u3002\u300d<\/i><\/p>\n

Syngene \u8207\u00a0Bristol Myers Squibb \u7684\u5408\u4f5c\u59cb\u65bc\u00a01998 \u5e74\uff0c\u4e26\u6700\u7d42\u4fc3\u6210\u00a0Biocon Bristol Myers Squibb Research and Development Center (BBRC) \u7684\u6210\u7acb\u3002\u8a72\u4e2d\u5fc3\u70ba\u00a0Syngene \u9996\u500b\u5c08\u5c6c\u7814\u767c\u4e2d\u5fc3\uff0c\u4e26\u65bc\u00a02009 \u5e74\u5168\u9762\u6295\u5165\u904b\u4f5c\u3002 \u591a\u5e74\u4f86\uff0cBBRC \u5df2\u767c\u5c55\u6210\u70ba\u00a0Bristol Myers Squibb \u7684\u91cd\u8981\u7b56\u7565\u6027\u7814\u767c\u57fa\u5730\uff0c\u652f\u63f4\u6db5\u84cb\u6a19\u9776\u8b58\u5225\u3001\u5148\u5c0e\u5316\u5408\u7269\u767c\u73fe\u3001\u5148\u5c0e\u512a\u5316\u3001\u88fd\u85e5\u958b\u767c\u3001\u5206\u5b50\u53ca\u7d30\u80de\u751f\u7269\u5b78\u3001\u86cb\u767d\u79d1\u5b78\u3001\u5206\u6790\u6e2c\u8a66\u751f\u7269\u5b78\u4ee5\u53ca\u81e8\u5e8a\u751f\u7269\u6a19\u8a8c\u7269\u7b49\u591a\u9805\u6574\u5408\u7814\u767c\u80fd\u529b\u3002 \u8a72\u4e2d\u5fc3\u76ee\u524d\u7d04\u6709\u00a0700 \u540d\u00a0Syngene \u79d1\u5b78\u5bb6\uff0c\u4f5c\u70ba\u00a0Bristol Myers Squibb \u5168\u7403\u7814\u7a76\u7d44\u7e54\u7684\u5ef6\u4f38\u5718\u968a\uff0c\u53c3\u8207\u6db5\u84cb\u5fc3\u8840\u7ba1\u3001\u7e96\u7dad\u5316\u3001\u514d\u75ab\u5b78\u53ca\u816b\u7624\u5b78\u7b49\u591a\u500b\u6cbb\u7642\u9818\u57df\u7684\u85e5\u7269\u767c\u73fe\u3001\u81e8\u5e8a\u524d\u958b\u767c\u53ca\u5c08\u5229\u7533\u8acb\u5de5\u4f5c\u3002<\/p>\n

\u81ea\u6210\u7acb\u4ee5\u4f86\uff0cBBRC \u5728\u52a0\u901f\u65b0\u578b\u5316\u5408\u7269\u7531\u65e9\u671f\u767c\u73fe\u63a8\u9032\u81f3\u9996\u6b21\u4eba\u9ad4\u7814\u7a76\u00a0(first-in-human) \u65b9\u9762\u767c\u63ee\u4e86\u95dc\u9375\u4f5c\u7528\uff0c\u5f9e\u800c\u5354\u52a9\u00a0Bristol Myers Squibb \u7e2e\u77ed\u7814\u767c\u5468\u671f\u4e26\u964d\u4f4e\u6574\u9ad4\u6210\u672c\u3002<\/p>\n

\u95dc\u65bc\u00a0Syngene<\/b><\/p>\n

Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE 398R01022) \u662f\u4e00\u5bb6\u6574\u5408\u79d1\u7814\u3001\u958b\u767c\u53ca\u88fd\u9020\u670d\u52d9\u516c\u53f8\uff0c\u670d\u52d9\u5c0d\u8c61\u6db5\u84cb\u5168\u7403\u88fd\u85e5\u3001\u751f\u7269\u79d1\u6280\u3001\u71df\u990a\u3001\u52d5\u7269\u4fdd\u5065\u3001\u6d88\u8cbb\u54c1\u53ca\u7279\u7a2e\u5316\u5b78\u54c1\u7b49\u884c\u696d\u3002\u00a0Syngene \u64c1\u6709\u8d85\u904e\u00a08,200 \u540d\u54e1\u5de5\u7684\u5c08\u696d\u5718\u968a\uff0c\u5176\u4e2d\u5305\u62ec\u00a05,600 \u540d\u79d1\u5b78\u5bb6\uff0c\u517c\u5177\u6df1\u539a\u5c08\u696d\u5be6\u529b\u8207\u898f\u6a21\u5316\u4ea4\u4ed8\u80fd\u529b\uff0c\u80fd\u5920\u8fc5\u901f\u63d0\u4f9b\u5353\u8d8a\u7684\u79d1\u5b78\u7814\u767c\u3001\u7a69\u5065\u7684\u6578\u64da\u5b89\u5168\u4fdd\u969c\u4ee5\u53ca\u4e16\u754c\u7d1a\u7684\u88fd\u9020\u670d\u52d9\uff0c\u5f9e\u800c\u52a0\u5feb\u7522\u54c1\u4e0a\u5e02\u6642\u7a0b\uff0c\u4e26\u964d\u4f4e\u5275\u65b0\u6210\u672c\u3002<\/p>\n

Syngene \u5728\u5370\u5ea6\u53ca\u7f8e\u570b\u8a2d\u6709\u8d85\u904e\u00a0250 \u842c\u5e73\u65b9\u544e\u7684\u5c08\u696d\u767c\u73fe\u3001\u958b\u767c\u53ca\u88fd\u9020\u8a2d\u65bd\uff0c\u670d\u52d9\u7d04\u00a0400 \u5bb6\u5168\u7403\u5ba2\u6236\uff0c\u8986\u84cb\u591a\u500b\u884c\u696d\u9818\u57df\uff0c\u5305\u62ec\u5f9e\u4e8b\u524d\u6cbf\u79d1\u7814\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u4ee5\u53ca\u00a0BMS\u3001GSK\u3001Zoetis \u53ca\u00a0Merck KGaA \u7b49\u8de8\u570b\u4f01\u696d\u3002 \u5982\u6b32\u4e86\u89e3\u66f4\u591a\u8a73\u60c5\uff0c\u8acb\u700f\u89bd\u00a0www.syngeneintl.com<\/a>\u3002 \u6709\u95dc\u672c\u516c\u53f8\u6700\u65b0\u7684\u74b0\u5883\u3001\u793e\u6703\u53ca\u7ba1\u6cbb\u00a0(ESG) \u5831\u544a\uff0c\u8acb\u53c3\u95b1 Syngene ESG Report\u3002<\/p>\n

\u5a92\u9ad4\u806f\u7d61\u4eba\uff1a<\/b><\/p>\n

Vijay Jeevanandham
Syngene International Limited
\u624b\u6a5f\u865f\u78bc\uff1a+91 8310914552
\u96fb\u90f5\uff1a\u00a0Vijay.Jeevanandham@syngeneintl.com<\/a><\/p>\n

Alex Heeley \/ Abdul Khalifeh
De Facto Communications
\u96fb\u8a71\uff1a+44 (0) 203 735 8165 \/ +44 (0) 7834784764
\u96fb\u90f5\uff1aa.khalifeh@defacto.co.uk<\/a>
\u96fb\u90f5\uff1aa.heeley@defacto.co.uk<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

\u5370\u5ea6\u73ed\u52a0\u7f85\u723e2026\u5e741\u670821…<\/p>\n","protected":false},"author":16,"featured_media":403648,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"fifu_image_url":"","fifu_image_alt":"","footnotes":""},"categories":[40567],"tags":[],"class_list":["post-403647","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-40567"],"acf":[],"yoast_head":"\nSyngene International \u5ef6\u9577\u8207 Bristol Myers Squibb \u7684\u9577\u671f\u79d1\u7814\u5408\u4f5c\u81f3 2035 \u5e74 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831<\/title>\n<meta name=\"description\" content=\"\u5370\u5ea6\u73ed\u52a0\u7f85\u723e2026\u5e741\u670821\u65e5 \/\u7f8e\u901a\u793e\/ -- \u5168\u7403\u5408\u7d04\u7814\u7a76\u3001\u958b\u767c\u53ca\u88fd\u9020\u6a5f\u69cb (CRDMO) Syngene International \u4eca\u65e5\u5ba3\u4f48\uff0c\u5c07\u5176\u8207 Bristol Myers Squibb \u4e4b\u9593\u9577\u671f\u7684\u7b56\u7565\u6027\u5408\u4f5c\u95dc\u4fc2\u5ef6\u9577\u81f3 2035 \u5e74\u3002 \u64f4\u5c55\u5f8c\u7684\u5354\u8b70\u9032\u4e00\u6b65\u64f4\u5927\u4e86\u6574\u5408\u670d\u52d9\u7684\u7bc4\u7587\uff0c\u6db5\u84cb\u85e5\u7269\u958b\u767c\u5168\u751f\u547d\u9031\u671f\uff0c\u5f9e\u7814\u767c\u63a2\u7d22\u968e\u6bb5\uff08\u5305\u62ec\u5316\u5b78\u3001\u751f\u7269\u5b78\u3001\u85e5\u7269\u4ee3\u8b1d\u8207\u85e5\u7269\u52d5\u529b\u5b78\uff09\u3001\u8f49\u8b6f\u79d1\u5b78\u3001\u88fd\u85e5\u958b\u767c\u8207\u88fd\u9020\u3001\u81e8\u5e8a\u8a66\u9a57\uff0c\u4ee5\u81f3\u6578\u64da\u8207\u8cc7\u8a0a\u79d1\u6280\u670d\u52d9\uff0c\u4ee5\u5be6\u73fe\u7531\u79d1\u7814\u5230\u5546\u696d\u5316\u7684\u7121\u7e2b\u63a8\u9032\u3002 \u6b64\u6b21\u5408\u4f5c\u7684\u64f4\u5c55\u6a19\u8a8c\u7740\u96d9\u65b9\u9081\u5165\u4e0b\u4e00\u968e\u6bb5\u7684\u589e\u9577\uff0c\u4e26\u9032\u4e00\u6b65\u978f\u56fa Syngene \u4f5c\u70ba\u7b56\u7565\u6027\u5408\u4f5c\u5925\u4f34\u7684\u5730\u4f4d\uff0c\u6301\u7e8c\u63d0\u4f9b\u6574\u5408\u5f0f\u3001\u7aef\u5230\u7aef\u7684\u79d1\u7814\u8207\u88fd\u9020\u89e3\u6c7a\u65b9\u6848\u3002 Syngene International Ltd. \u8463\u4e8b\u7e3d\u7d93\u7406\u517c\u884c\u653f\u7e3d\u88c1\u00a0Peter Bains \u8868\u793a\uff1a\u00a0\u300c\u6211\u5011\u8207\u00a0Bristol Myers Squibb \u7684\u5408\u4f5c\u95dc\u4fc2\u81f3\u4eca\u5df2\u903e\u00a025 \u5e74\uff0c\u4e26\u4ee5\u5353\u8d8a\u79d1\u7814\u3001\u71df\u904b\u53ef\u9760\u6027\uff0c\u4ee5\u53ca\u5171\u540c\u63a8\u52d5\u5275\u65b0\u7642\u6cd5\u767c\u5c55\u7684\u627f\u8afe\u70ba\u57fa\u790e\u3002 \u5c07\u5408\u4f5c\u5925\u4f34\u95dc\u4fc2\u5ef6\u9577\u81f3\u00a02035 \u5e74\u7684\u5354\u8b70\uff0c\u8b93\u6211\u5011\u80fd\u4ee5\u9577\u9054\u5341\u5e74\u6642\u9593\u7684\u8996\u91ce\uff0c\u5171\u540c\u898f\u5283\u672a\u4f86\u5728\u65b0\u80fd\u529b\u53ca\u57fa\u790e\u8a2d\u65bd\u65b9\u9762\u7684\u5efa\u8a2d\u3002 \u63a1\u53d6\u9577\u9060\u8996\u89d2\u662f\u6211\u5011\u5408\u4f5c\u95dc\u4fc2\u7684\u95dc\u9375\u7279\u9ede\uff0c\u70ba\u96d9\u65b9\u4f01\u696d\u5e36\u4f86\u7b56\u7565\u6027\u50f9\u503c\u3002 \u6211\u5011\u671f\u5f85\u652f\u63f4\u00a0BMS \u4e0b\u4e00\u6ce2\u7684\u767c\u73fe\u3001\u958b\u767c\u53ca\u88fd\u9020\u8a08\u5283\uff0c\u9019\u4e9b\u9805\u76ee\u6709\u6f5b\u529b\u70ba\u5168\u7403\u60a3\u8005\u5e36\u4f86\u66f4\u4f73\u7684\u6cbb\u7642\u6210\u679c\u3002\u300d Bristol Myers Squibb \u6cbb\u7642\u767c\u73fe\u79d1\u5b78\u9ad8\u7d1a\u526f\u7e3d\u88c1\u00a0Payal Sheth \u8868\u793a\uff1a\u00a0\u300c\u5728\u00a0Bristol Myers Squibb\uff0c\u6211\u5011\u6240\u505a\u7684\u4e00\u5207\u90fd\u4ee5\u60a3\u8005\u70ba\u8d77\u9ede\u3002 \u6211\u5011\u975e\u5e38\u91cd\u8996\u8207\u00a0Syngene \u4e4b\u9593\u6b77\u4e45\u5f4c\u65b0\u7684\u5408\u4f5c\u5925\u4f34\u95dc\u4fc2\uff0c\u8a72\u5408\u4f5c\u5728\u63a8\u52d5\u6211\u5011\u7684\u79d1\u7814\u62b1\u8ca0\u65b9\u9762\u767c\u63ee\u4e86\u95dc\u9375\u4f5c\u7528\u3002 \u6b64\u6b21\u5408\u4f5c\u7684\u64f4\u5c55\uff0c\u9ad4\u73fe\u4e86\u6211\u5011\u900f\u904e\u6709\u6548\u6574\u5408\u79d1\u7814\u3001\u958b\u767c\u53ca\u88fd\u9020\u80fd\u529b\uff0c\u63a8\u9032\u5275\u65b0\u79d1\u5b78\u7684\u627f\u8afe\uff0c\u4ee5\u52a0\u5feb\u5177\u7a81\u7834\u6027\u7684\u85e5\u7269\u4ea4\u4ed8\uff0c\u70ba\u5168\u7403\u6b63\u7b49\u5f85\u65b0\u6cbb\u7642\u65b9\u6848\u7684\u60a3\u8005\u5e36\u4f86\u5e0c\u671b\u3002\u300d Syngene \u8207\u00a0Bristol Myers Squibb \u7684\u5408\u4f5c\u59cb\u65bc\u00a01998 \u5e74\uff0c\u4e26\u6700\u7d42\u4fc3\u6210\u00a0Biocon Bristol Myers Squibb Research and Development Center (BBRC) \u7684\u6210\u7acb\u3002\u8a72\u4e2d\u5fc3\u70ba\u00a0Syngene \u9996\u500b\u5c08\u5c6c\u7814\u767c\u4e2d\u5fc3\uff0c\u4e26\u65bc\u00a02009 \u5e74\u5168\u9762\u6295\u5165\u904b\u4f5c\u3002 \u591a\u5e74\u4f86\uff0cBBRC \u5df2\u767c\u5c55\u6210\u70ba\u00a0Bristol Myers Squibb \u7684\u91cd\u8981\u7b56\u7565\u6027\u7814\u767c\u57fa\u5730\uff0c\u652f\u63f4\u6db5\u84cb\u6a19\u9776\u8b58\u5225\u3001\u5148\u5c0e\u5316\u5408\u7269\u767c\u73fe\u3001\u5148\u5c0e\u512a\u5316\u3001\u88fd\u85e5\u958b\u767c\u3001\u5206\u5b50\u53ca\u7d30\u80de\u751f\u7269\u5b78\u3001\u86cb\u767d\u79d1\u5b78\u3001\u5206\u6790\u6e2c\u8a66\u751f\u7269\u5b78\u4ee5\u53ca\u81e8\u5e8a\u751f\u7269\u6a19\u8a8c\u7269\u7b49\u591a\u9805\u6574\u5408\u7814\u767c\u80fd\u529b\u3002 \u8a72\u4e2d\u5fc3\u76ee\u524d\u7d04\u6709\u00a0700 \u540d\u00a0Syngene \u79d1\u5b78\u5bb6\uff0c\u4f5c\u70ba\u00a0Bristol Myers Squibb \u5168\u7403\u7814\u7a76\u7d44\u7e54\u7684\u5ef6\u4f38\u5718\u968a\uff0c\u53c3\u8207\u6db5\u84cb\u5fc3\u8840\u7ba1\u3001\u7e96\u7dad\u5316\u3001\u514d\u75ab\u5b78\u53ca\u816b\u7624\u5b78\u7b49\u591a\u500b\u6cbb\u7642\u9818\u57df\u7684\u85e5\u7269\u767c\u73fe\u3001\u81e8\u5e8a\u524d\u958b\u767c\u53ca\u5c08\u5229\u7533\u8acb\u5de5\u4f5c\u3002 \u81ea\u6210\u7acb\u4ee5\u4f86\uff0cBBRC \u5728\u52a0\u901f\u65b0\u578b\u5316\u5408\u7269\u7531\u65e9\u671f\u767c\u73fe\u63a8\u9032\u81f3\u9996\u6b21\u4eba\u9ad4\u7814\u7a76\u00a0(first-in-human) \u65b9\u9762\u767c\u63ee\u4e86\u95dc\u9375\u4f5c\u7528\uff0c\u5f9e\u800c\u5354\u52a9\u00a0Bristol Myers Squibb \u7e2e\u77ed\u7814\u767c\u5468\u671f\u4e26\u964d\u4f4e\u6574\u9ad4\u6210\u672c\u3002 \u95dc\u65bc\u00a0Syngene Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE 398R01022) \u662f\u4e00\u5bb6\u6574\u5408\u79d1\u7814\u3001\u958b\u767c\u53ca\u88fd\u9020\u670d\u52d9\u516c\u53f8\uff0c\u670d\u52d9\u5c0d\u8c61\u6db5\u84cb\u5168\u7403\u88fd\u85e5\u3001\u751f\u7269\u79d1\u6280\u3001\u71df\u990a\u3001\u52d5\u7269\u4fdd\u5065\u3001\u6d88\u8cbb\u54c1\u53ca\u7279\u7a2e\u5316\u5b78\u54c1\u7b49\u884c\u696d\u3002\u00a0Syngene \u64c1\u6709\u8d85\u904e\u00a08,200 \u540d\u54e1\u5de5\u7684\u5c08\u696d\u5718\u968a\uff0c\u5176\u4e2d\u5305\u62ec\u00a05,600 \u540d\u79d1\u5b78\u5bb6\uff0c\u517c\u5177\u6df1\u539a\u5c08\u696d\u5be6\u529b\u8207\u898f\u6a21\u5316\u4ea4\u4ed8\u80fd\u529b\uff0c\u80fd\u5920\u8fc5\u901f\u63d0\u4f9b\u5353\u8d8a\u7684\u79d1\u5b78\u7814\u767c\u3001\u7a69\u5065\u7684\u6578\u64da\u5b89\u5168\u4fdd\u969c\u4ee5\u53ca\u4e16\u754c\u7d1a\u7684\u88fd\u9020\u670d\u52d9\uff0c\u5f9e\u800c\u52a0\u5feb\u7522\u54c1\u4e0a\u5e02\u6642\u7a0b\uff0c\u4e26\u964d\u4f4e\u5275\u65b0\u6210\u672c\u3002 Syngene \u5728\u5370\u5ea6\u53ca\u7f8e\u570b\u8a2d\u6709\u8d85\u904e\u00a0250 \u842c\u5e73\u65b9\u544e\u7684\u5c08\u696d\u767c\u73fe\u3001\u958b\u767c\u53ca\u88fd\u9020\u8a2d\u65bd\uff0c\u670d\u52d9\u7d04\u00a0400 \u5bb6\u5168\u7403\u5ba2\u6236\uff0c\u8986\u84cb\u591a\u500b\u884c\u696d\u9818\u57df\uff0c\u5305\u62ec\u5f9e\u4e8b\u524d\u6cbf\u79d1\u7814\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u4ee5\u53ca\u00a0BMS\u3001GSK\u3001Zoetis \u53ca\u00a0Merck KGaA \u7b49\u8de8\u570b\u4f01\u696d\u3002 \u5982\u6b32\u4e86\u89e3\u66f4\u591a\u8a73\u60c5\uff0c\u8acb\u700f\u89bd\u00a0www.syngeneintl.com\u3002 \u6709\u95dc\u672c\u516c\u53f8\u6700\u65b0\u7684\u74b0\u5883\u3001\u793e\u6703\u53ca\u7ba1\u6cbb\u00a0(ESG) \u5831\u544a\uff0c\u8acb\u53c3\u95b1 Syngene ESG Report\u3002 \u5a92\u9ad4\u806f\u7d61\u4eba\uff1a Vijay JeevanandhamSyngene International Limited\u624b\u6a5f\u865f\u78bc\uff1a+91 8310914552\u96fb\u90f5\uff1a\u00a0Vijay.Jeevanandham@syngeneintl.com Alex Heeley \/ Abdul KhalifehDe Facto Communications\u96fb\u8a71\uff1a+44 (0) 203 735 8165 \/ +44 (0) 7834784764\u96fb\u90f5\uff1aa.khalifeh@defacto.co.uk\u96fb\u90f5\uff1aa.heeley@defacto.co.uk\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pingtungtimes.com.tw\/?p=403647\" \/>\n<meta property=\"og:locale\" content=\"zh_TW\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Syngene International \u5ef6\u9577\u8207 Bristol Myers Squibb \u7684\u9577\u671f\u79d1\u7814\u5408\u4f5c\u81f3 2035 \u5e74 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\" \/>\n<meta property=\"og:description\" content=\"\u5370\u5ea6\u73ed\u52a0\u7f85\u723e2026\u5e741\u670821\u65e5 \/\u7f8e\u901a\u793e\/ -- \u5168\u7403\u5408\u7d04\u7814\u7a76\u3001\u958b\u767c\u53ca\u88fd\u9020\u6a5f\u69cb (CRDMO) Syngene International \u4eca\u65e5\u5ba3\u4f48\uff0c\u5c07\u5176\u8207 Bristol Myers Squibb \u4e4b\u9593\u9577\u671f\u7684\u7b56\u7565\u6027\u5408\u4f5c\u95dc\u4fc2\u5ef6\u9577\u81f3 2035 \u5e74\u3002 \u64f4\u5c55\u5f8c\u7684\u5354\u8b70\u9032\u4e00\u6b65\u64f4\u5927\u4e86\u6574\u5408\u670d\u52d9\u7684\u7bc4\u7587\uff0c\u6db5\u84cb\u85e5\u7269\u958b\u767c\u5168\u751f\u547d\u9031\u671f\uff0c\u5f9e\u7814\u767c\u63a2\u7d22\u968e\u6bb5\uff08\u5305\u62ec\u5316\u5b78\u3001\u751f\u7269\u5b78\u3001\u85e5\u7269\u4ee3\u8b1d\u8207\u85e5\u7269\u52d5\u529b\u5b78\uff09\u3001\u8f49\u8b6f\u79d1\u5b78\u3001\u88fd\u85e5\u958b\u767c\u8207\u88fd\u9020\u3001\u81e8\u5e8a\u8a66\u9a57\uff0c\u4ee5\u81f3\u6578\u64da\u8207\u8cc7\u8a0a\u79d1\u6280\u670d\u52d9\uff0c\u4ee5\u5be6\u73fe\u7531\u79d1\u7814\u5230\u5546\u696d\u5316\u7684\u7121\u7e2b\u63a8\u9032\u3002 \u6b64\u6b21\u5408\u4f5c\u7684\u64f4\u5c55\u6a19\u8a8c\u7740\u96d9\u65b9\u9081\u5165\u4e0b\u4e00\u968e\u6bb5\u7684\u589e\u9577\uff0c\u4e26\u9032\u4e00\u6b65\u978f\u56fa Syngene \u4f5c\u70ba\u7b56\u7565\u6027\u5408\u4f5c\u5925\u4f34\u7684\u5730\u4f4d\uff0c\u6301\u7e8c\u63d0\u4f9b\u6574\u5408\u5f0f\u3001\u7aef\u5230\u7aef\u7684\u79d1\u7814\u8207\u88fd\u9020\u89e3\u6c7a\u65b9\u6848\u3002 Syngene International Ltd. \u8463\u4e8b\u7e3d\u7d93\u7406\u517c\u884c\u653f\u7e3d\u88c1\u00a0Peter Bains \u8868\u793a\uff1a\u00a0\u300c\u6211\u5011\u8207\u00a0Bristol Myers Squibb \u7684\u5408\u4f5c\u95dc\u4fc2\u81f3\u4eca\u5df2\u903e\u00a025 \u5e74\uff0c\u4e26\u4ee5\u5353\u8d8a\u79d1\u7814\u3001\u71df\u904b\u53ef\u9760\u6027\uff0c\u4ee5\u53ca\u5171\u540c\u63a8\u52d5\u5275\u65b0\u7642\u6cd5\u767c\u5c55\u7684\u627f\u8afe\u70ba\u57fa\u790e\u3002 \u5c07\u5408\u4f5c\u5925\u4f34\u95dc\u4fc2\u5ef6\u9577\u81f3\u00a02035 \u5e74\u7684\u5354\u8b70\uff0c\u8b93\u6211\u5011\u80fd\u4ee5\u9577\u9054\u5341\u5e74\u6642\u9593\u7684\u8996\u91ce\uff0c\u5171\u540c\u898f\u5283\u672a\u4f86\u5728\u65b0\u80fd\u529b\u53ca\u57fa\u790e\u8a2d\u65bd\u65b9\u9762\u7684\u5efa\u8a2d\u3002 \u63a1\u53d6\u9577\u9060\u8996\u89d2\u662f\u6211\u5011\u5408\u4f5c\u95dc\u4fc2\u7684\u95dc\u9375\u7279\u9ede\uff0c\u70ba\u96d9\u65b9\u4f01\u696d\u5e36\u4f86\u7b56\u7565\u6027\u50f9\u503c\u3002 \u6211\u5011\u671f\u5f85\u652f\u63f4\u00a0BMS \u4e0b\u4e00\u6ce2\u7684\u767c\u73fe\u3001\u958b\u767c\u53ca\u88fd\u9020\u8a08\u5283\uff0c\u9019\u4e9b\u9805\u76ee\u6709\u6f5b\u529b\u70ba\u5168\u7403\u60a3\u8005\u5e36\u4f86\u66f4\u4f73\u7684\u6cbb\u7642\u6210\u679c\u3002\u300d Bristol Myers Squibb \u6cbb\u7642\u767c\u73fe\u79d1\u5b78\u9ad8\u7d1a\u526f\u7e3d\u88c1\u00a0Payal Sheth \u8868\u793a\uff1a\u00a0\u300c\u5728\u00a0Bristol Myers Squibb\uff0c\u6211\u5011\u6240\u505a\u7684\u4e00\u5207\u90fd\u4ee5\u60a3\u8005\u70ba\u8d77\u9ede\u3002 \u6211\u5011\u975e\u5e38\u91cd\u8996\u8207\u00a0Syngene \u4e4b\u9593\u6b77\u4e45\u5f4c\u65b0\u7684\u5408\u4f5c\u5925\u4f34\u95dc\u4fc2\uff0c\u8a72\u5408\u4f5c\u5728\u63a8\u52d5\u6211\u5011\u7684\u79d1\u7814\u62b1\u8ca0\u65b9\u9762\u767c\u63ee\u4e86\u95dc\u9375\u4f5c\u7528\u3002 \u6b64\u6b21\u5408\u4f5c\u7684\u64f4\u5c55\uff0c\u9ad4\u73fe\u4e86\u6211\u5011\u900f\u904e\u6709\u6548\u6574\u5408\u79d1\u7814\u3001\u958b\u767c\u53ca\u88fd\u9020\u80fd\u529b\uff0c\u63a8\u9032\u5275\u65b0\u79d1\u5b78\u7684\u627f\u8afe\uff0c\u4ee5\u52a0\u5feb\u5177\u7a81\u7834\u6027\u7684\u85e5\u7269\u4ea4\u4ed8\uff0c\u70ba\u5168\u7403\u6b63\u7b49\u5f85\u65b0\u6cbb\u7642\u65b9\u6848\u7684\u60a3\u8005\u5e36\u4f86\u5e0c\u671b\u3002\u300d Syngene \u8207\u00a0Bristol Myers Squibb \u7684\u5408\u4f5c\u59cb\u65bc\u00a01998 \u5e74\uff0c\u4e26\u6700\u7d42\u4fc3\u6210\u00a0Biocon Bristol Myers Squibb Research and Development Center (BBRC) \u7684\u6210\u7acb\u3002\u8a72\u4e2d\u5fc3\u70ba\u00a0Syngene \u9996\u500b\u5c08\u5c6c\u7814\u767c\u4e2d\u5fc3\uff0c\u4e26\u65bc\u00a02009 \u5e74\u5168\u9762\u6295\u5165\u904b\u4f5c\u3002 \u591a\u5e74\u4f86\uff0cBBRC \u5df2\u767c\u5c55\u6210\u70ba\u00a0Bristol Myers Squibb \u7684\u91cd\u8981\u7b56\u7565\u6027\u7814\u767c\u57fa\u5730\uff0c\u652f\u63f4\u6db5\u84cb\u6a19\u9776\u8b58\u5225\u3001\u5148\u5c0e\u5316\u5408\u7269\u767c\u73fe\u3001\u5148\u5c0e\u512a\u5316\u3001\u88fd\u85e5\u958b\u767c\u3001\u5206\u5b50\u53ca\u7d30\u80de\u751f\u7269\u5b78\u3001\u86cb\u767d\u79d1\u5b78\u3001\u5206\u6790\u6e2c\u8a66\u751f\u7269\u5b78\u4ee5\u53ca\u81e8\u5e8a\u751f\u7269\u6a19\u8a8c\u7269\u7b49\u591a\u9805\u6574\u5408\u7814\u767c\u80fd\u529b\u3002 \u8a72\u4e2d\u5fc3\u76ee\u524d\u7d04\u6709\u00a0700 \u540d\u00a0Syngene \u79d1\u5b78\u5bb6\uff0c\u4f5c\u70ba\u00a0Bristol Myers Squibb \u5168\u7403\u7814\u7a76\u7d44\u7e54\u7684\u5ef6\u4f38\u5718\u968a\uff0c\u53c3\u8207\u6db5\u84cb\u5fc3\u8840\u7ba1\u3001\u7e96\u7dad\u5316\u3001\u514d\u75ab\u5b78\u53ca\u816b\u7624\u5b78\u7b49\u591a\u500b\u6cbb\u7642\u9818\u57df\u7684\u85e5\u7269\u767c\u73fe\u3001\u81e8\u5e8a\u524d\u958b\u767c\u53ca\u5c08\u5229\u7533\u8acb\u5de5\u4f5c\u3002 \u81ea\u6210\u7acb\u4ee5\u4f86\uff0cBBRC \u5728\u52a0\u901f\u65b0\u578b\u5316\u5408\u7269\u7531\u65e9\u671f\u767c\u73fe\u63a8\u9032\u81f3\u9996\u6b21\u4eba\u9ad4\u7814\u7a76\u00a0(first-in-human) \u65b9\u9762\u767c\u63ee\u4e86\u95dc\u9375\u4f5c\u7528\uff0c\u5f9e\u800c\u5354\u52a9\u00a0Bristol Myers Squibb \u7e2e\u77ed\u7814\u767c\u5468\u671f\u4e26\u964d\u4f4e\u6574\u9ad4\u6210\u672c\u3002 \u95dc\u65bc\u00a0Syngene Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE 398R01022) \u662f\u4e00\u5bb6\u6574\u5408\u79d1\u7814\u3001\u958b\u767c\u53ca\u88fd\u9020\u670d\u52d9\u516c\u53f8\uff0c\u670d\u52d9\u5c0d\u8c61\u6db5\u84cb\u5168\u7403\u88fd\u85e5\u3001\u751f\u7269\u79d1\u6280\u3001\u71df\u990a\u3001\u52d5\u7269\u4fdd\u5065\u3001\u6d88\u8cbb\u54c1\u53ca\u7279\u7a2e\u5316\u5b78\u54c1\u7b49\u884c\u696d\u3002\u00a0Syngene \u64c1\u6709\u8d85\u904e\u00a08,200 \u540d\u54e1\u5de5\u7684\u5c08\u696d\u5718\u968a\uff0c\u5176\u4e2d\u5305\u62ec\u00a05,600 \u540d\u79d1\u5b78\u5bb6\uff0c\u517c\u5177\u6df1\u539a\u5c08\u696d\u5be6\u529b\u8207\u898f\u6a21\u5316\u4ea4\u4ed8\u80fd\u529b\uff0c\u80fd\u5920\u8fc5\u901f\u63d0\u4f9b\u5353\u8d8a\u7684\u79d1\u5b78\u7814\u767c\u3001\u7a69\u5065\u7684\u6578\u64da\u5b89\u5168\u4fdd\u969c\u4ee5\u53ca\u4e16\u754c\u7d1a\u7684\u88fd\u9020\u670d\u52d9\uff0c\u5f9e\u800c\u52a0\u5feb\u7522\u54c1\u4e0a\u5e02\u6642\u7a0b\uff0c\u4e26\u964d\u4f4e\u5275\u65b0\u6210\u672c\u3002 Syngene \u5728\u5370\u5ea6\u53ca\u7f8e\u570b\u8a2d\u6709\u8d85\u904e\u00a0250 \u842c\u5e73\u65b9\u544e\u7684\u5c08\u696d\u767c\u73fe\u3001\u958b\u767c\u53ca\u88fd\u9020\u8a2d\u65bd\uff0c\u670d\u52d9\u7d04\u00a0400 \u5bb6\u5168\u7403\u5ba2\u6236\uff0c\u8986\u84cb\u591a\u500b\u884c\u696d\u9818\u57df\uff0c\u5305\u62ec\u5f9e\u4e8b\u524d\u6cbf\u79d1\u7814\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u4ee5\u53ca\u00a0BMS\u3001GSK\u3001Zoetis \u53ca\u00a0Merck KGaA \u7b49\u8de8\u570b\u4f01\u696d\u3002 \u5982\u6b32\u4e86\u89e3\u66f4\u591a\u8a73\u60c5\uff0c\u8acb\u700f\u89bd\u00a0www.syngeneintl.com\u3002 \u6709\u95dc\u672c\u516c\u53f8\u6700\u65b0\u7684\u74b0\u5883\u3001\u793e\u6703\u53ca\u7ba1\u6cbb\u00a0(ESG) \u5831\u544a\uff0c\u8acb\u53c3\u95b1 Syngene ESG Report\u3002 \u5a92\u9ad4\u806f\u7d61\u4eba\uff1a Vijay JeevanandhamSyngene International Limited\u624b\u6a5f\u865f\u78bc\uff1a+91 8310914552\u96fb\u90f5\uff1a\u00a0Vijay.Jeevanandham@syngeneintl.com Alex Heeley \/ Abdul KhalifehDe Facto Communications\u96fb\u8a71\uff1a+44 (0) 203 735 8165 \/ +44 (0) 7834784764\u96fb\u90f5\uff1aa.khalifeh@defacto.co.uk\u96fb\u90f5\uff1aa.heeley@defacto.co.uk\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pingtungtimes.com.tw\/?p=403647\" \/>\n<meta property=\"og:site_name\" content=\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pingtungnews\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-21T16:06:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1706\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u7f8e\u901a\u793e\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005:\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u7f8e\u901a\u793e\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9810\u4f30\u95b1\u8b80\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\u9418\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=403647#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=403647\"},\"author\":{\"name\":\"\u7f8e\u901a\u793e\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/person\\\/683b937f29ec1537972f6c41e22a2cf3\"},\"headline\":\"Syngene International \u5ef6\u9577\u8207 Bristol Myers Squibb \u7684\u9577\u671f\u79d1\u7814\u5408\u4f5c\u81f3 2035 \u5e74\",\"datePublished\":\"2026-01-21T16:06:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=403647\"},\"wordCount\":106,\"publisher\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=403647#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Syngene_Logo.jpg\",\"articleSection\":[\"\u7f8e\u901a\u793e\"],\"inLanguage\":\"zh-TW\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=403647\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=403647\",\"name\":\"Syngene International \u5ef6\u9577\u8207 Bristol Myers Squibb \u7684\u9577\u671f\u79d1\u7814\u5408\u4f5c\u81f3 2035 \u5e74 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=403647#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=403647#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Syngene_Logo.jpg\",\"datePublished\":\"2026-01-21T16:06:00+00:00\",\"description\":\"\u5370\u5ea6\u73ed\u52a0\u7f85\u723e2026\u5e741\u670821\u65e5 \\\/\u7f8e\u901a\u793e\\\/ -- \u5168\u7403\u5408\u7d04\u7814\u7a76\u3001\u958b\u767c\u53ca\u88fd\u9020\u6a5f\u69cb (CRDMO) Syngene International \u4eca\u65e5\u5ba3\u4f48\uff0c\u5c07\u5176\u8207 Bristol Myers Squibb \u4e4b\u9593\u9577\u671f\u7684\u7b56\u7565\u6027\u5408\u4f5c\u95dc\u4fc2\u5ef6\u9577\u81f3 2035 \u5e74\u3002 \u64f4\u5c55\u5f8c\u7684\u5354\u8b70\u9032\u4e00\u6b65\u64f4\u5927\u4e86\u6574\u5408\u670d\u52d9\u7684\u7bc4\u7587\uff0c\u6db5\u84cb\u85e5\u7269\u958b\u767c\u5168\u751f\u547d\u9031\u671f\uff0c\u5f9e\u7814\u767c\u63a2\u7d22\u968e\u6bb5\uff08\u5305\u62ec\u5316\u5b78\u3001\u751f\u7269\u5b78\u3001\u85e5\u7269\u4ee3\u8b1d\u8207\u85e5\u7269\u52d5\u529b\u5b78\uff09\u3001\u8f49\u8b6f\u79d1\u5b78\u3001\u88fd\u85e5\u958b\u767c\u8207\u88fd\u9020\u3001\u81e8\u5e8a\u8a66\u9a57\uff0c\u4ee5\u81f3\u6578\u64da\u8207\u8cc7\u8a0a\u79d1\u6280\u670d\u52d9\uff0c\u4ee5\u5be6\u73fe\u7531\u79d1\u7814\u5230\u5546\u696d\u5316\u7684\u7121\u7e2b\u63a8\u9032\u3002 \u6b64\u6b21\u5408\u4f5c\u7684\u64f4\u5c55\u6a19\u8a8c\u7740\u96d9\u65b9\u9081\u5165\u4e0b\u4e00\u968e\u6bb5\u7684\u589e\u9577\uff0c\u4e26\u9032\u4e00\u6b65\u978f\u56fa Syngene \u4f5c\u70ba\u7b56\u7565\u6027\u5408\u4f5c\u5925\u4f34\u7684\u5730\u4f4d\uff0c\u6301\u7e8c\u63d0\u4f9b\u6574\u5408\u5f0f\u3001\u7aef\u5230\u7aef\u7684\u79d1\u7814\u8207\u88fd\u9020\u89e3\u6c7a\u65b9\u6848\u3002 Syngene International Ltd. \u8463\u4e8b\u7e3d\u7d93\u7406\u517c\u884c\u653f\u7e3d\u88c1\u00a0Peter Bains \u8868\u793a\uff1a\u00a0\u300c\u6211\u5011\u8207\u00a0Bristol Myers Squibb \u7684\u5408\u4f5c\u95dc\u4fc2\u81f3\u4eca\u5df2\u903e\u00a025 \u5e74\uff0c\u4e26\u4ee5\u5353\u8d8a\u79d1\u7814\u3001\u71df\u904b\u53ef\u9760\u6027\uff0c\u4ee5\u53ca\u5171\u540c\u63a8\u52d5\u5275\u65b0\u7642\u6cd5\u767c\u5c55\u7684\u627f\u8afe\u70ba\u57fa\u790e\u3002 \u5c07\u5408\u4f5c\u5925\u4f34\u95dc\u4fc2\u5ef6\u9577\u81f3\u00a02035 \u5e74\u7684\u5354\u8b70\uff0c\u8b93\u6211\u5011\u80fd\u4ee5\u9577\u9054\u5341\u5e74\u6642\u9593\u7684\u8996\u91ce\uff0c\u5171\u540c\u898f\u5283\u672a\u4f86\u5728\u65b0\u80fd\u529b\u53ca\u57fa\u790e\u8a2d\u65bd\u65b9\u9762\u7684\u5efa\u8a2d\u3002 \u63a1\u53d6\u9577\u9060\u8996\u89d2\u662f\u6211\u5011\u5408\u4f5c\u95dc\u4fc2\u7684\u95dc\u9375\u7279\u9ede\uff0c\u70ba\u96d9\u65b9\u4f01\u696d\u5e36\u4f86\u7b56\u7565\u6027\u50f9\u503c\u3002 \u6211\u5011\u671f\u5f85\u652f\u63f4\u00a0BMS \u4e0b\u4e00\u6ce2\u7684\u767c\u73fe\u3001\u958b\u767c\u53ca\u88fd\u9020\u8a08\u5283\uff0c\u9019\u4e9b\u9805\u76ee\u6709\u6f5b\u529b\u70ba\u5168\u7403\u60a3\u8005\u5e36\u4f86\u66f4\u4f73\u7684\u6cbb\u7642\u6210\u679c\u3002\u300d Bristol Myers Squibb \u6cbb\u7642\u767c\u73fe\u79d1\u5b78\u9ad8\u7d1a\u526f\u7e3d\u88c1\u00a0Payal Sheth \u8868\u793a\uff1a\u00a0\u300c\u5728\u00a0Bristol Myers Squibb\uff0c\u6211\u5011\u6240\u505a\u7684\u4e00\u5207\u90fd\u4ee5\u60a3\u8005\u70ba\u8d77\u9ede\u3002 \u6211\u5011\u975e\u5e38\u91cd\u8996\u8207\u00a0Syngene \u4e4b\u9593\u6b77\u4e45\u5f4c\u65b0\u7684\u5408\u4f5c\u5925\u4f34\u95dc\u4fc2\uff0c\u8a72\u5408\u4f5c\u5728\u63a8\u52d5\u6211\u5011\u7684\u79d1\u7814\u62b1\u8ca0\u65b9\u9762\u767c\u63ee\u4e86\u95dc\u9375\u4f5c\u7528\u3002 \u6b64\u6b21\u5408\u4f5c\u7684\u64f4\u5c55\uff0c\u9ad4\u73fe\u4e86\u6211\u5011\u900f\u904e\u6709\u6548\u6574\u5408\u79d1\u7814\u3001\u958b\u767c\u53ca\u88fd\u9020\u80fd\u529b\uff0c\u63a8\u9032\u5275\u65b0\u79d1\u5b78\u7684\u627f\u8afe\uff0c\u4ee5\u52a0\u5feb\u5177\u7a81\u7834\u6027\u7684\u85e5\u7269\u4ea4\u4ed8\uff0c\u70ba\u5168\u7403\u6b63\u7b49\u5f85\u65b0\u6cbb\u7642\u65b9\u6848\u7684\u60a3\u8005\u5e36\u4f86\u5e0c\u671b\u3002\u300d Syngene \u8207\u00a0Bristol Myers Squibb \u7684\u5408\u4f5c\u59cb\u65bc\u00a01998 \u5e74\uff0c\u4e26\u6700\u7d42\u4fc3\u6210\u00a0Biocon Bristol Myers Squibb Research and Development Center (BBRC) \u7684\u6210\u7acb\u3002\u8a72\u4e2d\u5fc3\u70ba\u00a0Syngene \u9996\u500b\u5c08\u5c6c\u7814\u767c\u4e2d\u5fc3\uff0c\u4e26\u65bc\u00a02009 \u5e74\u5168\u9762\u6295\u5165\u904b\u4f5c\u3002 \u591a\u5e74\u4f86\uff0cBBRC \u5df2\u767c\u5c55\u6210\u70ba\u00a0Bristol Myers Squibb \u7684\u91cd\u8981\u7b56\u7565\u6027\u7814\u767c\u57fa\u5730\uff0c\u652f\u63f4\u6db5\u84cb\u6a19\u9776\u8b58\u5225\u3001\u5148\u5c0e\u5316\u5408\u7269\u767c\u73fe\u3001\u5148\u5c0e\u512a\u5316\u3001\u88fd\u85e5\u958b\u767c\u3001\u5206\u5b50\u53ca\u7d30\u80de\u751f\u7269\u5b78\u3001\u86cb\u767d\u79d1\u5b78\u3001\u5206\u6790\u6e2c\u8a66\u751f\u7269\u5b78\u4ee5\u53ca\u81e8\u5e8a\u751f\u7269\u6a19\u8a8c\u7269\u7b49\u591a\u9805\u6574\u5408\u7814\u767c\u80fd\u529b\u3002 \u8a72\u4e2d\u5fc3\u76ee\u524d\u7d04\u6709\u00a0700 \u540d\u00a0Syngene \u79d1\u5b78\u5bb6\uff0c\u4f5c\u70ba\u00a0Bristol Myers Squibb \u5168\u7403\u7814\u7a76\u7d44\u7e54\u7684\u5ef6\u4f38\u5718\u968a\uff0c\u53c3\u8207\u6db5\u84cb\u5fc3\u8840\u7ba1\u3001\u7e96\u7dad\u5316\u3001\u514d\u75ab\u5b78\u53ca\u816b\u7624\u5b78\u7b49\u591a\u500b\u6cbb\u7642\u9818\u57df\u7684\u85e5\u7269\u767c\u73fe\u3001\u81e8\u5e8a\u524d\u958b\u767c\u53ca\u5c08\u5229\u7533\u8acb\u5de5\u4f5c\u3002 \u81ea\u6210\u7acb\u4ee5\u4f86\uff0cBBRC \u5728\u52a0\u901f\u65b0\u578b\u5316\u5408\u7269\u7531\u65e9\u671f\u767c\u73fe\u63a8\u9032\u81f3\u9996\u6b21\u4eba\u9ad4\u7814\u7a76\u00a0(first-in-human) \u65b9\u9762\u767c\u63ee\u4e86\u95dc\u9375\u4f5c\u7528\uff0c\u5f9e\u800c\u5354\u52a9\u00a0Bristol Myers Squibb \u7e2e\u77ed\u7814\u767c\u5468\u671f\u4e26\u964d\u4f4e\u6574\u9ad4\u6210\u672c\u3002 \u95dc\u65bc\u00a0Syngene Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE 398R01022) \u662f\u4e00\u5bb6\u6574\u5408\u79d1\u7814\u3001\u958b\u767c\u53ca\u88fd\u9020\u670d\u52d9\u516c\u53f8\uff0c\u670d\u52d9\u5c0d\u8c61\u6db5\u84cb\u5168\u7403\u88fd\u85e5\u3001\u751f\u7269\u79d1\u6280\u3001\u71df\u990a\u3001\u52d5\u7269\u4fdd\u5065\u3001\u6d88\u8cbb\u54c1\u53ca\u7279\u7a2e\u5316\u5b78\u54c1\u7b49\u884c\u696d\u3002\u00a0Syngene \u64c1\u6709\u8d85\u904e\u00a08,200 \u540d\u54e1\u5de5\u7684\u5c08\u696d\u5718\u968a\uff0c\u5176\u4e2d\u5305\u62ec\u00a05,600 \u540d\u79d1\u5b78\u5bb6\uff0c\u517c\u5177\u6df1\u539a\u5c08\u696d\u5be6\u529b\u8207\u898f\u6a21\u5316\u4ea4\u4ed8\u80fd\u529b\uff0c\u80fd\u5920\u8fc5\u901f\u63d0\u4f9b\u5353\u8d8a\u7684\u79d1\u5b78\u7814\u767c\u3001\u7a69\u5065\u7684\u6578\u64da\u5b89\u5168\u4fdd\u969c\u4ee5\u53ca\u4e16\u754c\u7d1a\u7684\u88fd\u9020\u670d\u52d9\uff0c\u5f9e\u800c\u52a0\u5feb\u7522\u54c1\u4e0a\u5e02\u6642\u7a0b\uff0c\u4e26\u964d\u4f4e\u5275\u65b0\u6210\u672c\u3002 Syngene \u5728\u5370\u5ea6\u53ca\u7f8e\u570b\u8a2d\u6709\u8d85\u904e\u00a0250 \u842c\u5e73\u65b9\u544e\u7684\u5c08\u696d\u767c\u73fe\u3001\u958b\u767c\u53ca\u88fd\u9020\u8a2d\u65bd\uff0c\u670d\u52d9\u7d04\u00a0400 \u5bb6\u5168\u7403\u5ba2\u6236\uff0c\u8986\u84cb\u591a\u500b\u884c\u696d\u9818\u57df\uff0c\u5305\u62ec\u5f9e\u4e8b\u524d\u6cbf\u79d1\u7814\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u4ee5\u53ca\u00a0BMS\u3001GSK\u3001Zoetis \u53ca\u00a0Merck KGaA \u7b49\u8de8\u570b\u4f01\u696d\u3002 \u5982\u6b32\u4e86\u89e3\u66f4\u591a\u8a73\u60c5\uff0c\u8acb\u700f\u89bd\u00a0www.syngeneintl.com\u3002 \u6709\u95dc\u672c\u516c\u53f8\u6700\u65b0\u7684\u74b0\u5883\u3001\u793e\u6703\u53ca\u7ba1\u6cbb\u00a0(ESG) \u5831\u544a\uff0c\u8acb\u53c3\u95b1 Syngene ESG Report\u3002 \u5a92\u9ad4\u806f\u7d61\u4eba\uff1a Vijay JeevanandhamSyngene International Limited\u624b\u6a5f\u865f\u78bc\uff1a+91 8310914552\u96fb\u90f5\uff1a\u00a0Vijay.Jeevanandham@syngeneintl.com Alex Heeley \\\/ Abdul KhalifehDe Facto Communications\u96fb\u8a71\uff1a+44 (0) 203 735 8165 \\\/ +44 (0) 7834784764\u96fb\u90f5\uff1aa.khalifeh@defacto.co.uk\u96fb\u90f5\uff1aa.heeley@defacto.co.uk\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=403647#breadcrumb\"},\"inLanguage\":\"zh-TW\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=403647\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=403647#primaryimage\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Syngene_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Syngene_Logo.jpg\",\"width\":400,\"height\":98},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=403647#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9801\",\"item\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Syngene International \u5ef6\u9577\u8207 Bristol Myers Squibb \u7684\u9577\u671f\u79d1\u7814\u5408\u4f5c\u81f3 2035 \u5e74\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#website\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/\",\"name\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\",\"description\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831PingtungTimes\uff0c\u6700\u95dc\u5fc3\u5728\u5730\u7684\u5a92\u9ad4\",\"publisher\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-TW\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#organization\",\"name\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"contentUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"width\":150,\"height\":150,\"caption\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\"},\"image\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/pingtungnews\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/person\\\/683b937f29ec1537972f6c41e22a2cf3\",\"name\":\"\u7f8e\u901a\u793e\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g\",\"caption\":\"\u7f8e\u901a\u793e\"},\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?author=16\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Syngene International \u5ef6\u9577\u8207 Bristol Myers Squibb \u7684\u9577\u671f\u79d1\u7814\u5408\u4f5c\u81f3 2035 \u5e74 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","description":"\u5370\u5ea6\u73ed\u52a0\u7f85\u723e2026\u5e741\u670821\u65e5 \/\u7f8e\u901a\u793e\/ -- \u5168\u7403\u5408\u7d04\u7814\u7a76\u3001\u958b\u767c\u53ca\u88fd\u9020\u6a5f\u69cb (CRDMO) Syngene International \u4eca\u65e5\u5ba3\u4f48\uff0c\u5c07\u5176\u8207 Bristol Myers Squibb \u4e4b\u9593\u9577\u671f\u7684\u7b56\u7565\u6027\u5408\u4f5c\u95dc\u4fc2\u5ef6\u9577\u81f3 2035 \u5e74\u3002 \u64f4\u5c55\u5f8c\u7684\u5354\u8b70\u9032\u4e00\u6b65\u64f4\u5927\u4e86\u6574\u5408\u670d\u52d9\u7684\u7bc4\u7587\uff0c\u6db5\u84cb\u85e5\u7269\u958b\u767c\u5168\u751f\u547d\u9031\u671f\uff0c\u5f9e\u7814\u767c\u63a2\u7d22\u968e\u6bb5\uff08\u5305\u62ec\u5316\u5b78\u3001\u751f\u7269\u5b78\u3001\u85e5\u7269\u4ee3\u8b1d\u8207\u85e5\u7269\u52d5\u529b\u5b78\uff09\u3001\u8f49\u8b6f\u79d1\u5b78\u3001\u88fd\u85e5\u958b\u767c\u8207\u88fd\u9020\u3001\u81e8\u5e8a\u8a66\u9a57\uff0c\u4ee5\u81f3\u6578\u64da\u8207\u8cc7\u8a0a\u79d1\u6280\u670d\u52d9\uff0c\u4ee5\u5be6\u73fe\u7531\u79d1\u7814\u5230\u5546\u696d\u5316\u7684\u7121\u7e2b\u63a8\u9032\u3002 \u6b64\u6b21\u5408\u4f5c\u7684\u64f4\u5c55\u6a19\u8a8c\u7740\u96d9\u65b9\u9081\u5165\u4e0b\u4e00\u968e\u6bb5\u7684\u589e\u9577\uff0c\u4e26\u9032\u4e00\u6b65\u978f\u56fa Syngene \u4f5c\u70ba\u7b56\u7565\u6027\u5408\u4f5c\u5925\u4f34\u7684\u5730\u4f4d\uff0c\u6301\u7e8c\u63d0\u4f9b\u6574\u5408\u5f0f\u3001\u7aef\u5230\u7aef\u7684\u79d1\u7814\u8207\u88fd\u9020\u89e3\u6c7a\u65b9\u6848\u3002 Syngene International Ltd. \u8463\u4e8b\u7e3d\u7d93\u7406\u517c\u884c\u653f\u7e3d\u88c1\u00a0Peter Bains \u8868\u793a\uff1a\u00a0\u300c\u6211\u5011\u8207\u00a0Bristol Myers Squibb \u7684\u5408\u4f5c\u95dc\u4fc2\u81f3\u4eca\u5df2\u903e\u00a025 \u5e74\uff0c\u4e26\u4ee5\u5353\u8d8a\u79d1\u7814\u3001\u71df\u904b\u53ef\u9760\u6027\uff0c\u4ee5\u53ca\u5171\u540c\u63a8\u52d5\u5275\u65b0\u7642\u6cd5\u767c\u5c55\u7684\u627f\u8afe\u70ba\u57fa\u790e\u3002 \u5c07\u5408\u4f5c\u5925\u4f34\u95dc\u4fc2\u5ef6\u9577\u81f3\u00a02035 \u5e74\u7684\u5354\u8b70\uff0c\u8b93\u6211\u5011\u80fd\u4ee5\u9577\u9054\u5341\u5e74\u6642\u9593\u7684\u8996\u91ce\uff0c\u5171\u540c\u898f\u5283\u672a\u4f86\u5728\u65b0\u80fd\u529b\u53ca\u57fa\u790e\u8a2d\u65bd\u65b9\u9762\u7684\u5efa\u8a2d\u3002 \u63a1\u53d6\u9577\u9060\u8996\u89d2\u662f\u6211\u5011\u5408\u4f5c\u95dc\u4fc2\u7684\u95dc\u9375\u7279\u9ede\uff0c\u70ba\u96d9\u65b9\u4f01\u696d\u5e36\u4f86\u7b56\u7565\u6027\u50f9\u503c\u3002 \u6211\u5011\u671f\u5f85\u652f\u63f4\u00a0BMS \u4e0b\u4e00\u6ce2\u7684\u767c\u73fe\u3001\u958b\u767c\u53ca\u88fd\u9020\u8a08\u5283\uff0c\u9019\u4e9b\u9805\u76ee\u6709\u6f5b\u529b\u70ba\u5168\u7403\u60a3\u8005\u5e36\u4f86\u66f4\u4f73\u7684\u6cbb\u7642\u6210\u679c\u3002\u300d Bristol Myers Squibb \u6cbb\u7642\u767c\u73fe\u79d1\u5b78\u9ad8\u7d1a\u526f\u7e3d\u88c1\u00a0Payal Sheth \u8868\u793a\uff1a\u00a0\u300c\u5728\u00a0Bristol Myers Squibb\uff0c\u6211\u5011\u6240\u505a\u7684\u4e00\u5207\u90fd\u4ee5\u60a3\u8005\u70ba\u8d77\u9ede\u3002 \u6211\u5011\u975e\u5e38\u91cd\u8996\u8207\u00a0Syngene \u4e4b\u9593\u6b77\u4e45\u5f4c\u65b0\u7684\u5408\u4f5c\u5925\u4f34\u95dc\u4fc2\uff0c\u8a72\u5408\u4f5c\u5728\u63a8\u52d5\u6211\u5011\u7684\u79d1\u7814\u62b1\u8ca0\u65b9\u9762\u767c\u63ee\u4e86\u95dc\u9375\u4f5c\u7528\u3002 \u6b64\u6b21\u5408\u4f5c\u7684\u64f4\u5c55\uff0c\u9ad4\u73fe\u4e86\u6211\u5011\u900f\u904e\u6709\u6548\u6574\u5408\u79d1\u7814\u3001\u958b\u767c\u53ca\u88fd\u9020\u80fd\u529b\uff0c\u63a8\u9032\u5275\u65b0\u79d1\u5b78\u7684\u627f\u8afe\uff0c\u4ee5\u52a0\u5feb\u5177\u7a81\u7834\u6027\u7684\u85e5\u7269\u4ea4\u4ed8\uff0c\u70ba\u5168\u7403\u6b63\u7b49\u5f85\u65b0\u6cbb\u7642\u65b9\u6848\u7684\u60a3\u8005\u5e36\u4f86\u5e0c\u671b\u3002\u300d Syngene \u8207\u00a0Bristol Myers Squibb \u7684\u5408\u4f5c\u59cb\u65bc\u00a01998 \u5e74\uff0c\u4e26\u6700\u7d42\u4fc3\u6210\u00a0Biocon Bristol Myers Squibb Research and Development Center (BBRC) \u7684\u6210\u7acb\u3002\u8a72\u4e2d\u5fc3\u70ba\u00a0Syngene \u9996\u500b\u5c08\u5c6c\u7814\u767c\u4e2d\u5fc3\uff0c\u4e26\u65bc\u00a02009 \u5e74\u5168\u9762\u6295\u5165\u904b\u4f5c\u3002 \u591a\u5e74\u4f86\uff0cBBRC \u5df2\u767c\u5c55\u6210\u70ba\u00a0Bristol Myers Squibb \u7684\u91cd\u8981\u7b56\u7565\u6027\u7814\u767c\u57fa\u5730\uff0c\u652f\u63f4\u6db5\u84cb\u6a19\u9776\u8b58\u5225\u3001\u5148\u5c0e\u5316\u5408\u7269\u767c\u73fe\u3001\u5148\u5c0e\u512a\u5316\u3001\u88fd\u85e5\u958b\u767c\u3001\u5206\u5b50\u53ca\u7d30\u80de\u751f\u7269\u5b78\u3001\u86cb\u767d\u79d1\u5b78\u3001\u5206\u6790\u6e2c\u8a66\u751f\u7269\u5b78\u4ee5\u53ca\u81e8\u5e8a\u751f\u7269\u6a19\u8a8c\u7269\u7b49\u591a\u9805\u6574\u5408\u7814\u767c\u80fd\u529b\u3002 \u8a72\u4e2d\u5fc3\u76ee\u524d\u7d04\u6709\u00a0700 \u540d\u00a0Syngene \u79d1\u5b78\u5bb6\uff0c\u4f5c\u70ba\u00a0Bristol Myers Squibb \u5168\u7403\u7814\u7a76\u7d44\u7e54\u7684\u5ef6\u4f38\u5718\u968a\uff0c\u53c3\u8207\u6db5\u84cb\u5fc3\u8840\u7ba1\u3001\u7e96\u7dad\u5316\u3001\u514d\u75ab\u5b78\u53ca\u816b\u7624\u5b78\u7b49\u591a\u500b\u6cbb\u7642\u9818\u57df\u7684\u85e5\u7269\u767c\u73fe\u3001\u81e8\u5e8a\u524d\u958b\u767c\u53ca\u5c08\u5229\u7533\u8acb\u5de5\u4f5c\u3002 \u81ea\u6210\u7acb\u4ee5\u4f86\uff0cBBRC \u5728\u52a0\u901f\u65b0\u578b\u5316\u5408\u7269\u7531\u65e9\u671f\u767c\u73fe\u63a8\u9032\u81f3\u9996\u6b21\u4eba\u9ad4\u7814\u7a76\u00a0(first-in-human) \u65b9\u9762\u767c\u63ee\u4e86\u95dc\u9375\u4f5c\u7528\uff0c\u5f9e\u800c\u5354\u52a9\u00a0Bristol Myers Squibb \u7e2e\u77ed\u7814\u767c\u5468\u671f\u4e26\u964d\u4f4e\u6574\u9ad4\u6210\u672c\u3002 \u95dc\u65bc\u00a0Syngene Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE 398R01022) \u662f\u4e00\u5bb6\u6574\u5408\u79d1\u7814\u3001\u958b\u767c\u53ca\u88fd\u9020\u670d\u52d9\u516c\u53f8\uff0c\u670d\u52d9\u5c0d\u8c61\u6db5\u84cb\u5168\u7403\u88fd\u85e5\u3001\u751f\u7269\u79d1\u6280\u3001\u71df\u990a\u3001\u52d5\u7269\u4fdd\u5065\u3001\u6d88\u8cbb\u54c1\u53ca\u7279\u7a2e\u5316\u5b78\u54c1\u7b49\u884c\u696d\u3002\u00a0Syngene \u64c1\u6709\u8d85\u904e\u00a08,200 \u540d\u54e1\u5de5\u7684\u5c08\u696d\u5718\u968a\uff0c\u5176\u4e2d\u5305\u62ec\u00a05,600 \u540d\u79d1\u5b78\u5bb6\uff0c\u517c\u5177\u6df1\u539a\u5c08\u696d\u5be6\u529b\u8207\u898f\u6a21\u5316\u4ea4\u4ed8\u80fd\u529b\uff0c\u80fd\u5920\u8fc5\u901f\u63d0\u4f9b\u5353\u8d8a\u7684\u79d1\u5b78\u7814\u767c\u3001\u7a69\u5065\u7684\u6578\u64da\u5b89\u5168\u4fdd\u969c\u4ee5\u53ca\u4e16\u754c\u7d1a\u7684\u88fd\u9020\u670d\u52d9\uff0c\u5f9e\u800c\u52a0\u5feb\u7522\u54c1\u4e0a\u5e02\u6642\u7a0b\uff0c\u4e26\u964d\u4f4e\u5275\u65b0\u6210\u672c\u3002 Syngene \u5728\u5370\u5ea6\u53ca\u7f8e\u570b\u8a2d\u6709\u8d85\u904e\u00a0250 \u842c\u5e73\u65b9\u544e\u7684\u5c08\u696d\u767c\u73fe\u3001\u958b\u767c\u53ca\u88fd\u9020\u8a2d\u65bd\uff0c\u670d\u52d9\u7d04\u00a0400 \u5bb6\u5168\u7403\u5ba2\u6236\uff0c\u8986\u84cb\u591a\u500b\u884c\u696d\u9818\u57df\uff0c\u5305\u62ec\u5f9e\u4e8b\u524d\u6cbf\u79d1\u7814\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u4ee5\u53ca\u00a0BMS\u3001GSK\u3001Zoetis \u53ca\u00a0Merck KGaA \u7b49\u8de8\u570b\u4f01\u696d\u3002 \u5982\u6b32\u4e86\u89e3\u66f4\u591a\u8a73\u60c5\uff0c\u8acb\u700f\u89bd\u00a0www.syngeneintl.com\u3002 \u6709\u95dc\u672c\u516c\u53f8\u6700\u65b0\u7684\u74b0\u5883\u3001\u793e\u6703\u53ca\u7ba1\u6cbb\u00a0(ESG) \u5831\u544a\uff0c\u8acb\u53c3\u95b1 Syngene ESG Report\u3002 \u5a92\u9ad4\u806f\u7d61\u4eba\uff1a Vijay JeevanandhamSyngene International Limited\u624b\u6a5f\u865f\u78bc\uff1a+91 8310914552\u96fb\u90f5\uff1a\u00a0Vijay.Jeevanandham@syngeneintl.com Alex Heeley \/ Abdul KhalifehDe Facto Communications\u96fb\u8a71\uff1a+44 (0) 203 735 8165 \/ +44 (0) 7834784764\u96fb\u90f5\uff1aa.khalifeh@defacto.co.uk\u96fb\u90f5\uff1aa.heeley@defacto.co.uk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pingtungtimes.com.tw\/?p=403647","og_locale":"zh_TW","og_type":"article","og_title":"Syngene International \u5ef6\u9577\u8207 Bristol Myers Squibb \u7684\u9577\u671f\u79d1\u7814\u5408\u4f5c\u81f3 2035 \u5e74 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","og_description":"\u5370\u5ea6\u73ed\u52a0\u7f85\u723e2026\u5e741\u670821\u65e5 \/\u7f8e\u901a\u793e\/ -- \u5168\u7403\u5408\u7d04\u7814\u7a76\u3001\u958b\u767c\u53ca\u88fd\u9020\u6a5f\u69cb (CRDMO) Syngene International \u4eca\u65e5\u5ba3\u4f48\uff0c\u5c07\u5176\u8207 Bristol Myers Squibb \u4e4b\u9593\u9577\u671f\u7684\u7b56\u7565\u6027\u5408\u4f5c\u95dc\u4fc2\u5ef6\u9577\u81f3 2035 \u5e74\u3002 \u64f4\u5c55\u5f8c\u7684\u5354\u8b70\u9032\u4e00\u6b65\u64f4\u5927\u4e86\u6574\u5408\u670d\u52d9\u7684\u7bc4\u7587\uff0c\u6db5\u84cb\u85e5\u7269\u958b\u767c\u5168\u751f\u547d\u9031\u671f\uff0c\u5f9e\u7814\u767c\u63a2\u7d22\u968e\u6bb5\uff08\u5305\u62ec\u5316\u5b78\u3001\u751f\u7269\u5b78\u3001\u85e5\u7269\u4ee3\u8b1d\u8207\u85e5\u7269\u52d5\u529b\u5b78\uff09\u3001\u8f49\u8b6f\u79d1\u5b78\u3001\u88fd\u85e5\u958b\u767c\u8207\u88fd\u9020\u3001\u81e8\u5e8a\u8a66\u9a57\uff0c\u4ee5\u81f3\u6578\u64da\u8207\u8cc7\u8a0a\u79d1\u6280\u670d\u52d9\uff0c\u4ee5\u5be6\u73fe\u7531\u79d1\u7814\u5230\u5546\u696d\u5316\u7684\u7121\u7e2b\u63a8\u9032\u3002 \u6b64\u6b21\u5408\u4f5c\u7684\u64f4\u5c55\u6a19\u8a8c\u7740\u96d9\u65b9\u9081\u5165\u4e0b\u4e00\u968e\u6bb5\u7684\u589e\u9577\uff0c\u4e26\u9032\u4e00\u6b65\u978f\u56fa Syngene \u4f5c\u70ba\u7b56\u7565\u6027\u5408\u4f5c\u5925\u4f34\u7684\u5730\u4f4d\uff0c\u6301\u7e8c\u63d0\u4f9b\u6574\u5408\u5f0f\u3001\u7aef\u5230\u7aef\u7684\u79d1\u7814\u8207\u88fd\u9020\u89e3\u6c7a\u65b9\u6848\u3002 Syngene International Ltd. \u8463\u4e8b\u7e3d\u7d93\u7406\u517c\u884c\u653f\u7e3d\u88c1\u00a0Peter Bains \u8868\u793a\uff1a\u00a0\u300c\u6211\u5011\u8207\u00a0Bristol Myers Squibb \u7684\u5408\u4f5c\u95dc\u4fc2\u81f3\u4eca\u5df2\u903e\u00a025 \u5e74\uff0c\u4e26\u4ee5\u5353\u8d8a\u79d1\u7814\u3001\u71df\u904b\u53ef\u9760\u6027\uff0c\u4ee5\u53ca\u5171\u540c\u63a8\u52d5\u5275\u65b0\u7642\u6cd5\u767c\u5c55\u7684\u627f\u8afe\u70ba\u57fa\u790e\u3002 \u5c07\u5408\u4f5c\u5925\u4f34\u95dc\u4fc2\u5ef6\u9577\u81f3\u00a02035 \u5e74\u7684\u5354\u8b70\uff0c\u8b93\u6211\u5011\u80fd\u4ee5\u9577\u9054\u5341\u5e74\u6642\u9593\u7684\u8996\u91ce\uff0c\u5171\u540c\u898f\u5283\u672a\u4f86\u5728\u65b0\u80fd\u529b\u53ca\u57fa\u790e\u8a2d\u65bd\u65b9\u9762\u7684\u5efa\u8a2d\u3002 \u63a1\u53d6\u9577\u9060\u8996\u89d2\u662f\u6211\u5011\u5408\u4f5c\u95dc\u4fc2\u7684\u95dc\u9375\u7279\u9ede\uff0c\u70ba\u96d9\u65b9\u4f01\u696d\u5e36\u4f86\u7b56\u7565\u6027\u50f9\u503c\u3002 \u6211\u5011\u671f\u5f85\u652f\u63f4\u00a0BMS \u4e0b\u4e00\u6ce2\u7684\u767c\u73fe\u3001\u958b\u767c\u53ca\u88fd\u9020\u8a08\u5283\uff0c\u9019\u4e9b\u9805\u76ee\u6709\u6f5b\u529b\u70ba\u5168\u7403\u60a3\u8005\u5e36\u4f86\u66f4\u4f73\u7684\u6cbb\u7642\u6210\u679c\u3002\u300d Bristol Myers Squibb \u6cbb\u7642\u767c\u73fe\u79d1\u5b78\u9ad8\u7d1a\u526f\u7e3d\u88c1\u00a0Payal Sheth \u8868\u793a\uff1a\u00a0\u300c\u5728\u00a0Bristol Myers Squibb\uff0c\u6211\u5011\u6240\u505a\u7684\u4e00\u5207\u90fd\u4ee5\u60a3\u8005\u70ba\u8d77\u9ede\u3002 \u6211\u5011\u975e\u5e38\u91cd\u8996\u8207\u00a0Syngene \u4e4b\u9593\u6b77\u4e45\u5f4c\u65b0\u7684\u5408\u4f5c\u5925\u4f34\u95dc\u4fc2\uff0c\u8a72\u5408\u4f5c\u5728\u63a8\u52d5\u6211\u5011\u7684\u79d1\u7814\u62b1\u8ca0\u65b9\u9762\u767c\u63ee\u4e86\u95dc\u9375\u4f5c\u7528\u3002 \u6b64\u6b21\u5408\u4f5c\u7684\u64f4\u5c55\uff0c\u9ad4\u73fe\u4e86\u6211\u5011\u900f\u904e\u6709\u6548\u6574\u5408\u79d1\u7814\u3001\u958b\u767c\u53ca\u88fd\u9020\u80fd\u529b\uff0c\u63a8\u9032\u5275\u65b0\u79d1\u5b78\u7684\u627f\u8afe\uff0c\u4ee5\u52a0\u5feb\u5177\u7a81\u7834\u6027\u7684\u85e5\u7269\u4ea4\u4ed8\uff0c\u70ba\u5168\u7403\u6b63\u7b49\u5f85\u65b0\u6cbb\u7642\u65b9\u6848\u7684\u60a3\u8005\u5e36\u4f86\u5e0c\u671b\u3002\u300d Syngene \u8207\u00a0Bristol Myers Squibb \u7684\u5408\u4f5c\u59cb\u65bc\u00a01998 \u5e74\uff0c\u4e26\u6700\u7d42\u4fc3\u6210\u00a0Biocon Bristol Myers Squibb Research and Development Center (BBRC) \u7684\u6210\u7acb\u3002\u8a72\u4e2d\u5fc3\u70ba\u00a0Syngene \u9996\u500b\u5c08\u5c6c\u7814\u767c\u4e2d\u5fc3\uff0c\u4e26\u65bc\u00a02009 \u5e74\u5168\u9762\u6295\u5165\u904b\u4f5c\u3002 \u591a\u5e74\u4f86\uff0cBBRC \u5df2\u767c\u5c55\u6210\u70ba\u00a0Bristol Myers Squibb \u7684\u91cd\u8981\u7b56\u7565\u6027\u7814\u767c\u57fa\u5730\uff0c\u652f\u63f4\u6db5\u84cb\u6a19\u9776\u8b58\u5225\u3001\u5148\u5c0e\u5316\u5408\u7269\u767c\u73fe\u3001\u5148\u5c0e\u512a\u5316\u3001\u88fd\u85e5\u958b\u767c\u3001\u5206\u5b50\u53ca\u7d30\u80de\u751f\u7269\u5b78\u3001\u86cb\u767d\u79d1\u5b78\u3001\u5206\u6790\u6e2c\u8a66\u751f\u7269\u5b78\u4ee5\u53ca\u81e8\u5e8a\u751f\u7269\u6a19\u8a8c\u7269\u7b49\u591a\u9805\u6574\u5408\u7814\u767c\u80fd\u529b\u3002 \u8a72\u4e2d\u5fc3\u76ee\u524d\u7d04\u6709\u00a0700 \u540d\u00a0Syngene \u79d1\u5b78\u5bb6\uff0c\u4f5c\u70ba\u00a0Bristol Myers Squibb \u5168\u7403\u7814\u7a76\u7d44\u7e54\u7684\u5ef6\u4f38\u5718\u968a\uff0c\u53c3\u8207\u6db5\u84cb\u5fc3\u8840\u7ba1\u3001\u7e96\u7dad\u5316\u3001\u514d\u75ab\u5b78\u53ca\u816b\u7624\u5b78\u7b49\u591a\u500b\u6cbb\u7642\u9818\u57df\u7684\u85e5\u7269\u767c\u73fe\u3001\u81e8\u5e8a\u524d\u958b\u767c\u53ca\u5c08\u5229\u7533\u8acb\u5de5\u4f5c\u3002 \u81ea\u6210\u7acb\u4ee5\u4f86\uff0cBBRC \u5728\u52a0\u901f\u65b0\u578b\u5316\u5408\u7269\u7531\u65e9\u671f\u767c\u73fe\u63a8\u9032\u81f3\u9996\u6b21\u4eba\u9ad4\u7814\u7a76\u00a0(first-in-human) \u65b9\u9762\u767c\u63ee\u4e86\u95dc\u9375\u4f5c\u7528\uff0c\u5f9e\u800c\u5354\u52a9\u00a0Bristol Myers Squibb \u7e2e\u77ed\u7814\u767c\u5468\u671f\u4e26\u964d\u4f4e\u6574\u9ad4\u6210\u672c\u3002 \u95dc\u65bc\u00a0Syngene Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE 398R01022) \u662f\u4e00\u5bb6\u6574\u5408\u79d1\u7814\u3001\u958b\u767c\u53ca\u88fd\u9020\u670d\u52d9\u516c\u53f8\uff0c\u670d\u52d9\u5c0d\u8c61\u6db5\u84cb\u5168\u7403\u88fd\u85e5\u3001\u751f\u7269\u79d1\u6280\u3001\u71df\u990a\u3001\u52d5\u7269\u4fdd\u5065\u3001\u6d88\u8cbb\u54c1\u53ca\u7279\u7a2e\u5316\u5b78\u54c1\u7b49\u884c\u696d\u3002\u00a0Syngene \u64c1\u6709\u8d85\u904e\u00a08,200 \u540d\u54e1\u5de5\u7684\u5c08\u696d\u5718\u968a\uff0c\u5176\u4e2d\u5305\u62ec\u00a05,600 \u540d\u79d1\u5b78\u5bb6\uff0c\u517c\u5177\u6df1\u539a\u5c08\u696d\u5be6\u529b\u8207\u898f\u6a21\u5316\u4ea4\u4ed8\u80fd\u529b\uff0c\u80fd\u5920\u8fc5\u901f\u63d0\u4f9b\u5353\u8d8a\u7684\u79d1\u5b78\u7814\u767c\u3001\u7a69\u5065\u7684\u6578\u64da\u5b89\u5168\u4fdd\u969c\u4ee5\u53ca\u4e16\u754c\u7d1a\u7684\u88fd\u9020\u670d\u52d9\uff0c\u5f9e\u800c\u52a0\u5feb\u7522\u54c1\u4e0a\u5e02\u6642\u7a0b\uff0c\u4e26\u964d\u4f4e\u5275\u65b0\u6210\u672c\u3002 Syngene \u5728\u5370\u5ea6\u53ca\u7f8e\u570b\u8a2d\u6709\u8d85\u904e\u00a0250 \u842c\u5e73\u65b9\u544e\u7684\u5c08\u696d\u767c\u73fe\u3001\u958b\u767c\u53ca\u88fd\u9020\u8a2d\u65bd\uff0c\u670d\u52d9\u7d04\u00a0400 \u5bb6\u5168\u7403\u5ba2\u6236\uff0c\u8986\u84cb\u591a\u500b\u884c\u696d\u9818\u57df\uff0c\u5305\u62ec\u5f9e\u4e8b\u524d\u6cbf\u79d1\u7814\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u4ee5\u53ca\u00a0BMS\u3001GSK\u3001Zoetis \u53ca\u00a0Merck KGaA \u7b49\u8de8\u570b\u4f01\u696d\u3002 \u5982\u6b32\u4e86\u89e3\u66f4\u591a\u8a73\u60c5\uff0c\u8acb\u700f\u89bd\u00a0www.syngeneintl.com\u3002 \u6709\u95dc\u672c\u516c\u53f8\u6700\u65b0\u7684\u74b0\u5883\u3001\u793e\u6703\u53ca\u7ba1\u6cbb\u00a0(ESG) \u5831\u544a\uff0c\u8acb\u53c3\u95b1 Syngene ESG Report\u3002 \u5a92\u9ad4\u806f\u7d61\u4eba\uff1a Vijay JeevanandhamSyngene International Limited\u624b\u6a5f\u865f\u78bc\uff1a+91 8310914552\u96fb\u90f5\uff1a\u00a0Vijay.Jeevanandham@syngeneintl.com Alex Heeley \/ Abdul KhalifehDe Facto Communications\u96fb\u8a71\uff1a+44 (0) 203 735 8165 \/ +44 (0) 7834784764\u96fb\u90f5\uff1aa.khalifeh@defacto.co.uk\u96fb\u90f5\uff1aa.heeley@defacto.co.uk","og_url":"https:\/\/pingtungtimes.com.tw\/?p=403647","og_site_name":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","article_publisher":"https:\/\/www.facebook.com\/pingtungnews","article_published_time":"2026-01-21T16:06:00+00:00","og_image":[{"width":1706,"height":960,"url":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","type":"image\/jpeg"}],"author":"\u7f8e\u901a\u793e","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005:":"\u7f8e\u901a\u793e","\u9810\u4f30\u95b1\u8b80\u6642\u9593":"1 \u5206\u9418"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/pingtungtimes.com.tw\/?p=403647#article","isPartOf":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=403647"},"author":{"name":"\u7f8e\u901a\u793e","@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/person\/683b937f29ec1537972f6c41e22a2cf3"},"headline":"Syngene International \u5ef6\u9577\u8207 Bristol Myers Squibb \u7684\u9577\u671f\u79d1\u7814\u5408\u4f5c\u81f3 2035 \u5e74","datePublished":"2026-01-21T16:06:00+00:00","mainEntityOfPage":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=403647"},"wordCount":106,"publisher":{"@id":"https:\/\/pingtungtimes.com.tw\/#organization"},"image":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=403647#primaryimage"},"thumbnailUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2026\/01\/Syngene_Logo.jpg","articleSection":["\u7f8e\u901a\u793e"],"inLanguage":"zh-TW"},{"@type":"WebPage","@id":"https:\/\/pingtungtimes.com.tw\/?p=403647","url":"https:\/\/pingtungtimes.com.tw\/?p=403647","name":"Syngene International \u5ef6\u9577\u8207 Bristol Myers Squibb \u7684\u9577\u671f\u79d1\u7814\u5408\u4f5c\u81f3 2035 \u5e74 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","isPartOf":{"@id":"https:\/\/pingtungtimes.com.tw\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=403647#primaryimage"},"image":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=403647#primaryimage"},"thumbnailUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2026\/01\/Syngene_Logo.jpg","datePublished":"2026-01-21T16:06:00+00:00","description":"\u5370\u5ea6\u73ed\u52a0\u7f85\u723e2026\u5e741\u670821\u65e5 \/\u7f8e\u901a\u793e\/ -- \u5168\u7403\u5408\u7d04\u7814\u7a76\u3001\u958b\u767c\u53ca\u88fd\u9020\u6a5f\u69cb (CRDMO) Syngene International \u4eca\u65e5\u5ba3\u4f48\uff0c\u5c07\u5176\u8207 Bristol Myers Squibb \u4e4b\u9593\u9577\u671f\u7684\u7b56\u7565\u6027\u5408\u4f5c\u95dc\u4fc2\u5ef6\u9577\u81f3 2035 \u5e74\u3002 \u64f4\u5c55\u5f8c\u7684\u5354\u8b70\u9032\u4e00\u6b65\u64f4\u5927\u4e86\u6574\u5408\u670d\u52d9\u7684\u7bc4\u7587\uff0c\u6db5\u84cb\u85e5\u7269\u958b\u767c\u5168\u751f\u547d\u9031\u671f\uff0c\u5f9e\u7814\u767c\u63a2\u7d22\u968e\u6bb5\uff08\u5305\u62ec\u5316\u5b78\u3001\u751f\u7269\u5b78\u3001\u85e5\u7269\u4ee3\u8b1d\u8207\u85e5\u7269\u52d5\u529b\u5b78\uff09\u3001\u8f49\u8b6f\u79d1\u5b78\u3001\u88fd\u85e5\u958b\u767c\u8207\u88fd\u9020\u3001\u81e8\u5e8a\u8a66\u9a57\uff0c\u4ee5\u81f3\u6578\u64da\u8207\u8cc7\u8a0a\u79d1\u6280\u670d\u52d9\uff0c\u4ee5\u5be6\u73fe\u7531\u79d1\u7814\u5230\u5546\u696d\u5316\u7684\u7121\u7e2b\u63a8\u9032\u3002 \u6b64\u6b21\u5408\u4f5c\u7684\u64f4\u5c55\u6a19\u8a8c\u7740\u96d9\u65b9\u9081\u5165\u4e0b\u4e00\u968e\u6bb5\u7684\u589e\u9577\uff0c\u4e26\u9032\u4e00\u6b65\u978f\u56fa Syngene \u4f5c\u70ba\u7b56\u7565\u6027\u5408\u4f5c\u5925\u4f34\u7684\u5730\u4f4d\uff0c\u6301\u7e8c\u63d0\u4f9b\u6574\u5408\u5f0f\u3001\u7aef\u5230\u7aef\u7684\u79d1\u7814\u8207\u88fd\u9020\u89e3\u6c7a\u65b9\u6848\u3002 Syngene International Ltd. \u8463\u4e8b\u7e3d\u7d93\u7406\u517c\u884c\u653f\u7e3d\u88c1\u00a0Peter Bains \u8868\u793a\uff1a\u00a0\u300c\u6211\u5011\u8207\u00a0Bristol Myers Squibb \u7684\u5408\u4f5c\u95dc\u4fc2\u81f3\u4eca\u5df2\u903e\u00a025 \u5e74\uff0c\u4e26\u4ee5\u5353\u8d8a\u79d1\u7814\u3001\u71df\u904b\u53ef\u9760\u6027\uff0c\u4ee5\u53ca\u5171\u540c\u63a8\u52d5\u5275\u65b0\u7642\u6cd5\u767c\u5c55\u7684\u627f\u8afe\u70ba\u57fa\u790e\u3002 \u5c07\u5408\u4f5c\u5925\u4f34\u95dc\u4fc2\u5ef6\u9577\u81f3\u00a02035 \u5e74\u7684\u5354\u8b70\uff0c\u8b93\u6211\u5011\u80fd\u4ee5\u9577\u9054\u5341\u5e74\u6642\u9593\u7684\u8996\u91ce\uff0c\u5171\u540c\u898f\u5283\u672a\u4f86\u5728\u65b0\u80fd\u529b\u53ca\u57fa\u790e\u8a2d\u65bd\u65b9\u9762\u7684\u5efa\u8a2d\u3002 \u63a1\u53d6\u9577\u9060\u8996\u89d2\u662f\u6211\u5011\u5408\u4f5c\u95dc\u4fc2\u7684\u95dc\u9375\u7279\u9ede\uff0c\u70ba\u96d9\u65b9\u4f01\u696d\u5e36\u4f86\u7b56\u7565\u6027\u50f9\u503c\u3002 \u6211\u5011\u671f\u5f85\u652f\u63f4\u00a0BMS \u4e0b\u4e00\u6ce2\u7684\u767c\u73fe\u3001\u958b\u767c\u53ca\u88fd\u9020\u8a08\u5283\uff0c\u9019\u4e9b\u9805\u76ee\u6709\u6f5b\u529b\u70ba\u5168\u7403\u60a3\u8005\u5e36\u4f86\u66f4\u4f73\u7684\u6cbb\u7642\u6210\u679c\u3002\u300d Bristol Myers Squibb \u6cbb\u7642\u767c\u73fe\u79d1\u5b78\u9ad8\u7d1a\u526f\u7e3d\u88c1\u00a0Payal Sheth \u8868\u793a\uff1a\u00a0\u300c\u5728\u00a0Bristol Myers Squibb\uff0c\u6211\u5011\u6240\u505a\u7684\u4e00\u5207\u90fd\u4ee5\u60a3\u8005\u70ba\u8d77\u9ede\u3002 \u6211\u5011\u975e\u5e38\u91cd\u8996\u8207\u00a0Syngene \u4e4b\u9593\u6b77\u4e45\u5f4c\u65b0\u7684\u5408\u4f5c\u5925\u4f34\u95dc\u4fc2\uff0c\u8a72\u5408\u4f5c\u5728\u63a8\u52d5\u6211\u5011\u7684\u79d1\u7814\u62b1\u8ca0\u65b9\u9762\u767c\u63ee\u4e86\u95dc\u9375\u4f5c\u7528\u3002 \u6b64\u6b21\u5408\u4f5c\u7684\u64f4\u5c55\uff0c\u9ad4\u73fe\u4e86\u6211\u5011\u900f\u904e\u6709\u6548\u6574\u5408\u79d1\u7814\u3001\u958b\u767c\u53ca\u88fd\u9020\u80fd\u529b\uff0c\u63a8\u9032\u5275\u65b0\u79d1\u5b78\u7684\u627f\u8afe\uff0c\u4ee5\u52a0\u5feb\u5177\u7a81\u7834\u6027\u7684\u85e5\u7269\u4ea4\u4ed8\uff0c\u70ba\u5168\u7403\u6b63\u7b49\u5f85\u65b0\u6cbb\u7642\u65b9\u6848\u7684\u60a3\u8005\u5e36\u4f86\u5e0c\u671b\u3002\u300d Syngene \u8207\u00a0Bristol Myers Squibb \u7684\u5408\u4f5c\u59cb\u65bc\u00a01998 \u5e74\uff0c\u4e26\u6700\u7d42\u4fc3\u6210\u00a0Biocon Bristol Myers Squibb Research and Development Center (BBRC) \u7684\u6210\u7acb\u3002\u8a72\u4e2d\u5fc3\u70ba\u00a0Syngene \u9996\u500b\u5c08\u5c6c\u7814\u767c\u4e2d\u5fc3\uff0c\u4e26\u65bc\u00a02009 \u5e74\u5168\u9762\u6295\u5165\u904b\u4f5c\u3002 \u591a\u5e74\u4f86\uff0cBBRC \u5df2\u767c\u5c55\u6210\u70ba\u00a0Bristol Myers Squibb \u7684\u91cd\u8981\u7b56\u7565\u6027\u7814\u767c\u57fa\u5730\uff0c\u652f\u63f4\u6db5\u84cb\u6a19\u9776\u8b58\u5225\u3001\u5148\u5c0e\u5316\u5408\u7269\u767c\u73fe\u3001\u5148\u5c0e\u512a\u5316\u3001\u88fd\u85e5\u958b\u767c\u3001\u5206\u5b50\u53ca\u7d30\u80de\u751f\u7269\u5b78\u3001\u86cb\u767d\u79d1\u5b78\u3001\u5206\u6790\u6e2c\u8a66\u751f\u7269\u5b78\u4ee5\u53ca\u81e8\u5e8a\u751f\u7269\u6a19\u8a8c\u7269\u7b49\u591a\u9805\u6574\u5408\u7814\u767c\u80fd\u529b\u3002 \u8a72\u4e2d\u5fc3\u76ee\u524d\u7d04\u6709\u00a0700 \u540d\u00a0Syngene \u79d1\u5b78\u5bb6\uff0c\u4f5c\u70ba\u00a0Bristol Myers Squibb \u5168\u7403\u7814\u7a76\u7d44\u7e54\u7684\u5ef6\u4f38\u5718\u968a\uff0c\u53c3\u8207\u6db5\u84cb\u5fc3\u8840\u7ba1\u3001\u7e96\u7dad\u5316\u3001\u514d\u75ab\u5b78\u53ca\u816b\u7624\u5b78\u7b49\u591a\u500b\u6cbb\u7642\u9818\u57df\u7684\u85e5\u7269\u767c\u73fe\u3001\u81e8\u5e8a\u524d\u958b\u767c\u53ca\u5c08\u5229\u7533\u8acb\u5de5\u4f5c\u3002 \u81ea\u6210\u7acb\u4ee5\u4f86\uff0cBBRC \u5728\u52a0\u901f\u65b0\u578b\u5316\u5408\u7269\u7531\u65e9\u671f\u767c\u73fe\u63a8\u9032\u81f3\u9996\u6b21\u4eba\u9ad4\u7814\u7a76\u00a0(first-in-human) \u65b9\u9762\u767c\u63ee\u4e86\u95dc\u9375\u4f5c\u7528\uff0c\u5f9e\u800c\u5354\u52a9\u00a0Bristol Myers Squibb \u7e2e\u77ed\u7814\u767c\u5468\u671f\u4e26\u964d\u4f4e\u6574\u9ad4\u6210\u672c\u3002 \u95dc\u65bc\u00a0Syngene Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE 398R01022) \u662f\u4e00\u5bb6\u6574\u5408\u79d1\u7814\u3001\u958b\u767c\u53ca\u88fd\u9020\u670d\u52d9\u516c\u53f8\uff0c\u670d\u52d9\u5c0d\u8c61\u6db5\u84cb\u5168\u7403\u88fd\u85e5\u3001\u751f\u7269\u79d1\u6280\u3001\u71df\u990a\u3001\u52d5\u7269\u4fdd\u5065\u3001\u6d88\u8cbb\u54c1\u53ca\u7279\u7a2e\u5316\u5b78\u54c1\u7b49\u884c\u696d\u3002\u00a0Syngene \u64c1\u6709\u8d85\u904e\u00a08,200 \u540d\u54e1\u5de5\u7684\u5c08\u696d\u5718\u968a\uff0c\u5176\u4e2d\u5305\u62ec\u00a05,600 \u540d\u79d1\u5b78\u5bb6\uff0c\u517c\u5177\u6df1\u539a\u5c08\u696d\u5be6\u529b\u8207\u898f\u6a21\u5316\u4ea4\u4ed8\u80fd\u529b\uff0c\u80fd\u5920\u8fc5\u901f\u63d0\u4f9b\u5353\u8d8a\u7684\u79d1\u5b78\u7814\u767c\u3001\u7a69\u5065\u7684\u6578\u64da\u5b89\u5168\u4fdd\u969c\u4ee5\u53ca\u4e16\u754c\u7d1a\u7684\u88fd\u9020\u670d\u52d9\uff0c\u5f9e\u800c\u52a0\u5feb\u7522\u54c1\u4e0a\u5e02\u6642\u7a0b\uff0c\u4e26\u964d\u4f4e\u5275\u65b0\u6210\u672c\u3002 Syngene \u5728\u5370\u5ea6\u53ca\u7f8e\u570b\u8a2d\u6709\u8d85\u904e\u00a0250 \u842c\u5e73\u65b9\u544e\u7684\u5c08\u696d\u767c\u73fe\u3001\u958b\u767c\u53ca\u88fd\u9020\u8a2d\u65bd\uff0c\u670d\u52d9\u7d04\u00a0400 \u5bb6\u5168\u7403\u5ba2\u6236\uff0c\u8986\u84cb\u591a\u500b\u884c\u696d\u9818\u57df\uff0c\u5305\u62ec\u5f9e\u4e8b\u524d\u6cbf\u79d1\u7814\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u4ee5\u53ca\u00a0BMS\u3001GSK\u3001Zoetis \u53ca\u00a0Merck KGaA \u7b49\u8de8\u570b\u4f01\u696d\u3002 \u5982\u6b32\u4e86\u89e3\u66f4\u591a\u8a73\u60c5\uff0c\u8acb\u700f\u89bd\u00a0www.syngeneintl.com\u3002 \u6709\u95dc\u672c\u516c\u53f8\u6700\u65b0\u7684\u74b0\u5883\u3001\u793e\u6703\u53ca\u7ba1\u6cbb\u00a0(ESG) \u5831\u544a\uff0c\u8acb\u53c3\u95b1 Syngene ESG Report\u3002 \u5a92\u9ad4\u806f\u7d61\u4eba\uff1a Vijay JeevanandhamSyngene International Limited\u624b\u6a5f\u865f\u78bc\uff1a+91 8310914552\u96fb\u90f5\uff1a\u00a0Vijay.Jeevanandham@syngeneintl.com Alex Heeley \/ Abdul KhalifehDe Facto Communications\u96fb\u8a71\uff1a+44 (0) 203 735 8165 \/ +44 (0) 7834784764\u96fb\u90f5\uff1aa.khalifeh@defacto.co.uk\u96fb\u90f5\uff1aa.heeley@defacto.co.uk","breadcrumb":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=403647#breadcrumb"},"inLanguage":"zh-TW","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pingtungtimes.com.tw\/?p=403647"]}]},{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/pingtungtimes.com.tw\/?p=403647#primaryimage","url":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2026\/01\/Syngene_Logo.jpg","contentUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2026\/01\/Syngene_Logo.jpg","width":400,"height":98},{"@type":"BreadcrumbList","@id":"https:\/\/pingtungtimes.com.tw\/?p=403647#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9801","item":"https:\/\/pingtungtimes.com.tw\/"},{"@type":"ListItem","position":2,"name":"Syngene International \u5ef6\u9577\u8207 Bristol Myers Squibb \u7684\u9577\u671f\u79d1\u7814\u5408\u4f5c\u81f3 2035 \u5e74"}]},{"@type":"WebSite","@id":"https:\/\/pingtungtimes.com.tw\/#website","url":"https:\/\/pingtungtimes.com.tw\/","name":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","description":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831PingtungTimes\uff0c\u6700\u95dc\u5fc3\u5728\u5730\u7684\u5a92\u9ad4","publisher":{"@id":"https:\/\/pingtungtimes.com.tw\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pingtungtimes.com.tw\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-TW"},{"@type":"Organization","@id":"https:\/\/pingtungtimes.com.tw\/#organization","name":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","url":"https:\/\/pingtungtimes.com.tw\/","logo":{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/logo\/image\/","url":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","contentUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","width":150,"height":150,"caption":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831"},"image":{"@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pingtungnews"]},{"@type":"Person","@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/person\/683b937f29ec1537972f6c41e22a2cf3","name":"\u7f8e\u901a\u793e","image":{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/secure.gravatar.com\/avatar\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g","caption":"\u7f8e\u901a\u793e"},"url":"https:\/\/pingtungtimes.com.tw\/?author=16"}]}},"_links":{"self":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/403647","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=403647"}],"version-history":[{"count":0,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/403647\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/media\/403648"}],"wp:attachment":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=403647"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=403647"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=403647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}